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ABSTRACT 
COGNITIVE AND PSYCHOSOCIAL FACTORS ASSOCIATED WITH SARCOPENIA IN 
OLDER ADULTS 
 
by 
Murad Taani 
The University of Wisconsin Milwaukee, 2017 
Under the Supervision of Dr. Christine Kovach 
 
Objectives: To describe the muscle mass, strength, and function of older adults living in 
residential care apartment complexes (RCACs) and examine the association between self-
efficacy for exercise, depressive symptoms, social support and sarcopenia. The convergent 
validity of Muscle Mechanography (MM) when compared to the traditional muscle function and 
strength tests was also tested. 
Design: Secondary data analysis of baseline data from a clinical trial. 
Setting: One RCAC in the Midwestern United States.  
Participants: Thirty-one older adults living in one RCAC.  
Measurement: Muscle mass was measured by bioelectrical impedance spectroscopy. Muscle 
function was evaluated by the Short Physical Performance Battery test, Timed Up and Go test, 
and MM. Grip strength was measured by a Jamar® hand dynamometer. Self-efficacy for 
exercise was measured by the Self-efficacy for Exercise Scale. Depressive symptoms were 
measured by the Geriatric Depression Scale. Social support was measured by the Lubben Social 
Network Scale. 
Results: Participants had lower values of muscle mass, strength, and function compared to 
values obtained in previous research. A sex difference exists for muscle mass, strength, and 
 iii 
 
function. The findings showed a trend for individuals with high self-efficacy, without depressive 
symptoms, and with strong social support to present greater muscle mass, strength, and function. 
The findings also demonstrated convergent validity across all the examined measures of muscle 
function and strength.  
Conclusion: This study is only one of a few to describe the muscle outcomes and evaluate the 
relationship between selected cognitive and psychosocial factors and sarcopenia among older 
adults living in RCACs. The preliminary findings of this study warrant further investigation of 
an intervention aimed at maintaining or improving the muscle outcomes of RCAC residents. 
While the interpretation of findings should be presented with caution and replicated with other 
samples, this study may provide a new understanding about the muscle outcomes and the 
relationship between self-efficacy for exercise, depressive symptoms, and social support and 
sarcopenia. Improved understanding of muscle outcomes and the relationship between cognitive 
and psychosocial factors and sarcopenia is crucial. The findings also provided a new evidence 
about MM as a new technology to quantitively assess muscle function in older adults, potentially 
making this a valuable research tool. 
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CHAPTER 1 
 
This chapter introduces the problem of decreased muscle mass, strength, and function in 
older adults living in residential care apartment complexes (RCACs). This problem is commonly 
referred to as sarcopenia. The terms, decreased muscle mass, strength, and function and 
sarcopenia will be used interchangeably in this study. In this study the term RCACs refers to 
facilities licensed by the state at a non-nursing home level of care, which provide room, board, 
24-hour oversight, and minimal hours of assistance with activities of daily living. This study will 
fill gaps in the literature in three areas that are introduced in this chapter; it will a) describe the 
characteristics of muscle mass, strength, and function in older adults living in RCACs; b) 
describe the relationship of select cognitive and psychosocial factors to sarcopenia; and c) 
examine the convergent validity of Muscle Mechanography (MM) method with traditional 
muscle function tests. This chapter describes prevalence and significance as well as an 
introduction to the potential risk factors associated with decreased muscle mass, strength, and 
function among older adults. Gaps in the literature and the purpose of this study are given. The 
Individual and Family Self-management Theory (IFSMT) is described, conceptual definitions 
are provided, and the application of this theory to the study is discussed.  
Introduction to the Problem  
 
The reduction of muscle mass, strength, and function is one of the most consistent 
changes that occurs with aging and is considered one of the main causes of disability in older 
adults (Bruyère et al., 2016; Fielding et al., 2011; Morley, 2012). Recent estimates indicate that 
up to 45% of older adults in the United States suffer from sarcopenia (Janssen, Shepard, 
Katzmarzyk, & Roubenoff, 2004). Older adults with sarcopenia are at great risk for disastrous 
health outcomes such as premature death and disability caused by falls, fractures, head injuries, 
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limited mobility, and impaired daily functioning (Bruyère et al., 2016; Buehring, Krueger, & 
Binkley, 2010; Janssen et al., 2004; Morley, 2012). Sarcopenia also leads to an increased use of 
nursing homes, long-term care (LTC) facilities, and hospital inpatient treatment (Janssen et al., 
2004). These negative health outcomes are costly to the individual, the healthcare system, and 
society as a whole (Bruyère et al., 2016; Morley, 2012). 
Several medical explanations for sarcopenia have been proposed related to genetic 
factors, endocrine issues, hormonal changes, protein synthesis, proteolysis, and inflammatory 
processes (Fielding et al., 2011; Henwood, Keogh, Reid, Jordan, & Senior, 2014). While many 
of these mechanisms and their relationship to the onset and progression of sarcopenia are well-
understood, the cognitive and psychosocial risk factors for developing sarcopenia are poorly 
understood (Brady, Straight, & Evans, 2014; Campbell & Vallis, 2014; Henwood et al., 2014). A 
greater understanding of the factors contributing to sarcopenia in older adults is needed 
(Henwood et al., 2014). As sarcopenia is highly prevalent, identifying the treatable risk factors of 
sarcopenia is considered to be a crucial step to prevent decline in muscle mass, strength, and 
function in older adults (Fielding et al., 2011). Exploring these factors may enable the 
development of interventions to prevent or decrease potential consequences of sarcopenia in 
older adults.  
Prevalence and Significance 
 
Researchers estimated that more than 50% of older adults suffer from sarcopenia around 
the world (Cruz-Jentoft, Landi, Topinkova, & Michel, 2010). In the United States, researchers 
estimate that 45% of the elderly population is sarcopenic and 64% of adults over 65 years of age 
reported limitations in at least one domain of physical function including walking, climbing, 
standing, and sitting (Janssen et al., 2004, McAuley, Szabo, Gothe, & Olson, 2011). Morley 
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(2012) reported that there are 3.6 million older adults in the United States who are sarcopenic. In 
the New Mexico Elder Health Survey study, the prevalence of sarcopenia was determined to be 
over 50% in individuals older than 80 years (Baumgartner et al., 1998). In a systematic review 
by Cruz-Jentoft et al. (2014), the prevalence of sarcopenia in older adults was 1–33% across 
multiple populations and communities. Cruz-Jentoft et al. (2014) reported that the rates of 
sarcopenia vary across settings, such as in the community (1-29%), LTC facilities (14–33%), and 
among patients (10%) in acute care hospitals. A second systematic review revealed that the 
prevalence of sarcopenia in the older adults ranged from 0.0% to 85.4% in men and 0.1% to 
33.6% in women (Pagotto & Silveira, 2014).  
Sarcopenia is a public health problem, and preventing disability in older adults is a 
national priority (Bruyère et al., 2016; Ferrucci et al., 2004). The reduction of muscle mass, 
strength, and function leads to a cascade of negative health outcomes including the loss of 
physical function, which represents the major prognostic indicator for the development of 
physical disability (Bruyère et al., 2016; Janssen, Heymsfield, & Ross, 2002). This loss begins 
with weakness of the lower extremities which contributes to difficulties in rising from a chair 
and getting out of bed, slow gait speed, balance problem, and falls (Barbat-Artigas et al., 2013; 
Kamel, 2003; Mijnarends et al., 2015).  
With advancing age, sarcopenia-related impairment in physical function becomes severe 
and leads to increased risk for falls, reduced ability to perform activities of daily living, increased 
use of LTC facilities and nursing homes, hospitalization, and morbidity and mortality (Bruyère et 
al., 2016; Clark & Manini, 2010; Cruz-Jentoft et al., 2010; Hirani et al., 2015; Janssen, 2010; 
Morley, 2012; Newman et al., 2006). These negative consequences decrease the quality of life of 
older adults and result in a substantial increase in healthcare costs (Bruyère et al., 2016; Morley, 
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2012). Sarcopenia has been estimated to cost the United States health system around $18.5 
billion a year (Bruyère et al., 2016). As the aging population increases, the negative impact of 
sarcopenia on the elderly and the healthcare system is projected to rise (Bruyère et al., 2016; 
Janssen et al., 2004).  
According to the Administration on Aging (2012), older adults 65 years of age and older 
are expected to increase from 43.1 million in 2012 to 79.7 million by 2040 and older adults over 
the age of 85 years will triple from 5.9 million in 2012 to 14.1 million by 2040. Once sarcopenia-
related functional decline becomes apparent in this population, older adults will have difficulty 
recovering from it (Cruz-Jentoff, et al., 2010). Thus, nurses and other healthcare professionals 
have a pivotal role to play in improving muscle mass, strength, and function and preventing 
disability in older adults. Knowledge about the risk factors for muscle weakness and impaired 
muscle function is important to develop tailored intervention programs that ameliorate the 
antecedents and muscle strength and function themselves. This knowledge can also consequently 
prevent disability and improve mobility in older adults and decrease healthcare costs.  
Assessment of Muscle Function in Older Adults: Measurement Issues 
 
Increased dependency and impairments are considered a major reason for transfer from 
RCACs to more restrictive living environments such as LTC and nursing homes. Researchers 
suggested that increased impairments may be related to a lack of appropriate assessment and 
treatment (Giuliani et al., 2008; Roberts et al., 2013). Most studies on RCACs residents only 
report general functional ability such as Activities of Daily Living (ADL), and there are no 
benchmarks for functional data (Giuliani et al., 2008; Kerse, Butler, Robinson, Todd, 2004; 
Roberts et al., 2013; Zimmerman et al., 2005). Although measures of ADL are valuable for 
identifying disability level, they are not useful for detecting modifiable muscle function 
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impairments and functional limitations that lead to disability (Gibson et al., 2010; Giuliani et al., 
2008). Therefore, performing more sophisticated assessment of muscle function is needed to 
identify limitations, understand the predictive value of specific impairments, and to target 
intervention modalities in older adults living in RCACs (Giuliani et al., 2008; Guralnik et al., 
1994). Measures that provide more specific information regarding the muscular function include 
Muscle Mechanography (MM), the Short Physical Performance Battery (SPPB), and the Timed 
Up and Go (TUG) (Buehring et al., 2010; Guralnik et al., 1994; Minneci et al., 2015).  
Understanding with precision the muscle function of older adults living in RCACs is 
important. It provides the ability to distinguish older adults at risk for placement into LTC 
facilities or nursing homes due to sarcopenia and the sequelae of sarcopenia from those who are 
more likely to successfully age in their home environment. Knowledge of this at-risk group may 
also assist in developing interventions to improve or maintain functional status and prevent or 
delay transfer to more restrictive living environments. Maintaining or improving functional 
status is associated with enhanced quality life and decreased use of expensive healthcare services 
(Fielding et al., 2011; Giuliani et al., 2008).  
A new technology such as MM provides the possibility to obtain precise measures of 
muscle function and benchmarks for functional data (Buehring et al., 2010; Siglinsky et al., 
2015). MM was developed to overcome some shortcomings of the traditional muscle function 
tests and to provide an objective quantification of muscle function (power and force) by using 
maximal two-leg maximal countermovement jumps, serial hopping, or heel raises performed on 
a ground reaction force platform. MM has been used in research and clinical settings (Buehring 
et al., 2010; Siglinsky et al., 2015). However, data comparing MM with traditional muscle 
function tests is limited and more research is needed to validate MM with other widely used 
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muscle function tests in older adults (Buehring et al., 2015; Rittweger, Schiessl, Felsenberg, & 
Runge, 2004; Siglinsky et al., 2015). This study will examine the relationship between MM and 
other traditional muscle function tests including SPPB, TUG, and grip strength. 
The Individual and Family Self-management Theory  
 
The selection of a theoretical framework is critical to quantitative research as it provides 
the rationale for investigating a particular research problem. This study will use the theoretical 
foundation provided by the individual and family self-management theory (IFSMT) (Ryan & 
Sawin, 2009; Ryan & Sawin, 2013). According to the IFSMT, self-management is a process by 
which individuals and families use knowledge and beliefs, self-regulation skills and abilities, and 
social facilitation to achieve health-related outcomes (Ryan & Sawin, 2009). The IFSMT can 
potentially provide greater insight into the self-management behaviors in older adults to prevent 
sarcopenia and improve muscle outcomes. The IFSMT can provide a framework for assessing, 
planning, and implementing a theory based approach to the care of older adults and facilitate 
optimal health outcomes, particularly muscle mass, strength, and function. The IFSMT is 
depicted in Figure 1. 
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Figure 1. The Individual and Family Self-Management Theory. 
 
The premise of the IFMST is that self-management is a complex dynamic phenomenon 
consisting of three dimensions: context, process, and outcomes (Ryan & Sawin, 2013). The 
theory incorporates cognitive and psychosocial concepts, such as self-efficacy, depression, and 
social support, which are relevant to identifying potential risk factors that contribute to 
sarcopenia in older adults. Ryan and Sawin (2013) postulate that contextual and process factors 
influence individual and family engagement in the process of self-management and these factors 
are antecedent to proximal and distal outcomes. Enhancing the individuals’ and families’ self-
management processes leads to more positive health outcomes (Ryan & Sawin, 2013). 
Contextual factors include risks, protective, and individual factors such as depression and social 
support. The process factors (or the process of self-management) is influenced by concepts that 
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affect individuals’ knowledge and beliefs in their abilities such as the level of self-efficacy. The 
self-management behaviors are noted as a proximal outcome such as engaging in physical 
activity, managing depression, and developing a strong social network. Distal outcomes include 
health status (e.g., muscle mass, strength, and function), quality of life, and direct and indirect 
healthcare costs (Ryan & Sawin, 2013). Self-efficacy, depression, and social support concepts 
are selected for inclusion in the theoretical framework and are identified in the next section.  
Introduction to Potential Risk Factors for Sarcopenia 
 
The IFSMT model has been used to explain the self-management of calcium and vitamin 
D intake in women with osteoporosis (Ryan, Maierle, Csuka, Thomson, & Szabo, 2013). The 
model was also used to describe the self-management of medications in frail older adults 
receiving home healthcare services (Marek et al., 2013). However, the IFSMT model has not 
been used to study the potential risk factors for sarcopenia in older adults. The IFSMT has been 
modified to provide the foundational concepts for this research and to focus on concepts that 
might be relevant to the development of sarcopenia in older adults (Figure 2).  
The decline in muscle mass, strength, and function has a complex and multifactorial 
etiology, which contributes to the phenomenon of sarcopenia (Cruz-Jentoft et al., 2010; Fielding 
et al., 2011; Morley, 2012). Although evidence has shown that malnutrition and physical 
inactivity are associated factors for sarcopenia, limited evidence was found about other potential 
factors including self-efficacy for exercise, depression, and social support. These factors have 
received less attention in this area of research and require further study (Brady et al., 2014; 
Campbell & Vallis, 2014; Goisser et al., 2015; Henwood et al., 2014; Kim et al., 2011). If the 
relationship between self-efficacy for exercise, depression, and social support to sarcopenia 
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could be better understood and addressed, it could positively impact muscle outcomes and 
functional status in older adults.  
 
 
Figure 2. Application of Individual & Family Self-management Theory on Sarcopenia. 
 
Physical activity. There is considerable evidence that exercise and physical activity are 
effective approaches to decrease the decline in muscle mass, strength, and function (Cruz-Jentoft 
et al., 2014; Cruz-Jentoft et al., 2010; Morley, Anker, & Haehling, 2014). Physical activity 
causes the muscles to contract, and that contraction stimulates the release of muscle growth 
factors (insulin growth and mechanogrowth factors). Release of muscle growth factors activates 
satellite cells and enables protein synthesis, which in turn, leads to muscle regeneration (Cruz-
Jentoft et al., 2010, Kamel, 2003; Morley, 2012). People who are physically inactive or lead a 
sedentary lifestyle are less likely to stimulate the muscle regeneration process, making them 
more susceptible to developing sarcopenia (Gianoudis, Bailey, & Daly, 2014; Morley, 2012). 
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New research shows that sarcopenia is less likely to be present among individuals with high 
levels of physical activity and that physical inactivity is predictive of sarcopenia in older adults 
(Figueiredo et al., 2014; Landi et al., 2012; Lee et al., 2007). In addition, sarcopenia was less 
likely to be present among participants with high levels of physical activity. Gianoudis et al. 
(2014) reported that greater overall sitting time is associated with an increased risk of sarcopenia. 
Therefore, researchers need to further explore which factors might underlie any effects of 
physical activity on muscle outcome and physical function in older adults to guide and 
implement tailored intervention programs designed for this population. 
Self-efficacy. The concept of self-efficacy was first introduced by Albert Bandura as a 
result of his psychological research in 1977. Self-efficacy is defined as people’s judgments of 
their capabilities to carry out courses of action required to attain designated types of 
performances (Bandura, 1977). Self-efficacy has been considered a strong predictor for the level 
of physical activity and consistently associated with physical activity and well-being of older 
adults (Goisser et al., 2015; McAuley et al., 2011). Self-efficacy can enhance or impede the 
motivation to exercise and be active. Older adults with a high level of self-efficacy are able to set 
and achieve specific physical activity goals. These individuals have the commitment to engage in 
routine physical activity regimens for a sustained period of time. In contrast, low self-efficacy 
among older adults is associated with failure to engage in specific physical activity regimens for 
a sustained period of time leading to physical inactivity and sedentary lifestyle (McAuley et al., 
2011). 
Older adults may not have a high level of self-efficacy that is required to engage in 
routine physical activity regimens. Likewise, if older adults do not believe that engaging in 
physical activities will make difference in their mobility and muscle outcomes, they may lack 
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outcome expectancy and have low levels of self-efficacy (McAuley et al., 2011). Additionally, 
falls are considered a major public health problem and a main cause of morbidity and immobility 
in older adults, particularly among RCACs and nursing homes residents (Berry & Miller, 2008). 
Falls may increase fear of injury, which leads to low self-efficacy and self-imposed limitation of 
activity (Berry & Miller, 2008), and consequently negatively influences muscle outcome and 
physical function in older adults. 
Depression. Depression, which is both prevalent and undertreated in older adults, has 
deleterious consequences among older adults. Depression can negatively influence mobility, 
cognitive function, perceived self-efficacy, and self-management behaviors (Cramm et al., 2012; 
Fiske, Wetherell, & Gatz, 2009). Evidence shows that depression is a significant risk factor for 
development of sedentary lifestyle and decreased level of physical activity due to low motivation 
(Fiske et al., 2009; Roshanaei-Moghaddam, Katon, & Russo, 2009). As depression is strongly 
associated with physical inactivity and immobility, there may be an association between 
depression and sarcopenia.  
Depression also compromises the nutritional status of older adults (Fiske et al., 2009), 
and consequently triggers substantial muscle loss. Recent studies demonstrated that malnutrition 
is significantly associated with sarcopenia in community-dwelling older adults (Landi et al., 
2012; Santos et al., 2015; Volpato et al., 2014). Studies have shown that proper body mass index 
(BMI) and adequate protein intake are important for proper muscle mass and function and these 
are also key components of prevention and management of sarcopenia (Bauer et al., 2013; 
Beaudart et al., 2014; Cruz-Jenoft et al., 2010; Morley et al., 2010; Muir & Montero-Odasso, 
2011).  
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Additionally, the literature indicates that depression and malnutrition can activate the 
immune system, which increases the production of inflammatory cytokines and C-reactive 
protein. Activating the inflammatory processes amplifies chronic catabolic conditions and 
reduces muscle mass in older adults (Alexandre, Duarte, Santos, Wong, & Lebrão, 2014; Cesari 
et al., 2004). Hence, because depression shares a relationship with known risk factors associated 
with sarcopenia (physical inactivity, malnutrition, and inflammatory processes), there may also 
be an association between depression and sarcopenia. Depression, when in combination with 
other factors, such as increasing old age, co-morbidities, and inadequate social support, can serve 
to compound and accelerate difficulties experienced with muscle mass, strength, and function. 
Social support. Social support has captured the attention of gerontology researchers who 
seek to understand how this multi-dimensional concept influences the aging process of older 
adults. Social support can be defined as “information leading the subject to believe that he is 
cared for and loved, esteemed, and a member of a network of mutual obligations” (Cobb, 1976). 
One of the primary dimensions of social support is the structural dimension, which refers to 
individuals’ degree of social involvement or embeddedness and the composition and size of their 
social network (Chen & Silverstein, 2000). Family and friends are an important source of support 
for older adults with chronic conditions that leads to greater adherence to self-management 
(Chen & Wang, 2007). Social support system functions as an environmental resource that 
facilitates self-management by meeting social interaction needs and enhancing an individual’s 
motivation. 
Social support is considered one of most important factors that impacts the relationship 
between self-efficacy and self-management behaviors and predicts the physical health in older 
adults (Gallant, 2003). Being in a supportive social network leads to beneficial effects on 
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motivation, coping, psychological well-being, and self-management (Chen & Wang, 2007; 
Gallant, 2003). People experience different life-course exposures and daily life events that 
threaten their ability to perform the activities of daily living in a normal manner or engage in 
physical activity/exercise regimens (Yeom, Fleury, & Keller, 2008). While older adults who 
have strong social support are less likely to lead inactive lifestyles and be depressed, individuals 
with poor social support systems are prone to be isolated, depressed, and inactive (Wallace, 
Theou, Pena, Rockwood, & Andrew, 2015; Yeom et al., 2008). These negative consequences of 
poor social support may negatively impact physical function and muscle outcome in older adults. 
Strong and effective social support systems for older adults are related to a reduced risk for 
mobility deficits and depression, suggesting that strong social support may reduce or prevent 
disability in older adults (Wallace et al., 2015; Yeom et al., 2008). 
Pain. While pain is not a normal part of aging, it is experienced daily by a majority of 
older adults due to chronic conditions such as osteoarthritis, rheumatoid arthritis, and 
neuropathic disorders. Undertreated pain in older adults has significant functional, cognitive, and 
emotional consequences (Kovach, 2013). Pain was also found to be a factor that reduces physical 
activity and directly contributes to the progression of sarcopenia in older adults (Scott, Blizzard, 
Fell, & Jones, 2012). Since pain is associated with sarcopenia, pain must be considered in this 
study and there is a need to control for the influence of pain when examining the relationship 
between self-efficacy for exercise, depression, and social support in regards to sarcopenia.  
In summary, the adapted theoretical framework based on the IFSMT is a dynamic 
framework that shows the interactive relationship between self-efficacy for exercise, depression, 
and social support in regards to sarcopenia. The framework shows that self-efficacy for exercise, 
depression, and social support may contribute to sarcopenia in older adults. This adapted 
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framework also reveals how these factors may influence muscle mass, strength, and function in 
older adults. Accordingly, the adapted theoretical framework represents a logical and dynamic 
design that could be useful to describe and explain the phenomenon of sarcopenia and its 
associated risk factors in older adults living in RCACs. Ultimately, this framework will also 
inform the research design, data collection and analysis, and discussion of the implications.  
Other Terms/Definitions 
 
Bioimpedance spectroscopy (BIS). A device used to measure the body composition of 
lean body mass (Yamada et al., 2013). 
Convergent validity. The extent to which different tools that are designed to measure the 
same construct correlate with each other (Polit & Beck, 2012).  
Muscle function. The basic function of a muscle in generating power and force. Muscle 
power is the product of force production and the velocity at which the force is produced. Muscle 
force is the total force required of muscles to move the body (Buehring et al., 2010). 
Muscle mechanography (MM).  A novel method that provides an objective 
quantification of muscle function parameters including muscle power and muscle force (Taani, 
Kovach, &  Buehring, 2010).  
Muscle mass. The body composition of lean body mass (Buehring et al., 2010). 
Muscle strength. The ability of a muscle or muscle group to exert a maximal force or 
torque at a specific velocity during a muscle contraction (Verbrugge & Jette, 1994). Muscle 
strength in this study refers to handgrip strength, which is the maximal amount of force the 
dominant hand can produce isometrically. Handgrip strength is measured by using a hand 
dynamometer. 
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 Residential care apartment complexes (RCACs). Facilities licensed by the state at a 
non-nursing home level of care, which provide room, board, 24-hour oversight, and minimal 
hours of assistance with activities of daily living (Giuliani et al., 2008). 
Sarcopenia. The reduction in muscle mass, strength, and function in older adults 
(Morley, 2012). 
 Short physical performance battery (SPPB). A traditional muscle function test that 
consists of: gait speed as determined by a four-meter walk, timed repeated chair rises, and 
standing balance tests (Guralnik et al., 1994). 
 Timed up and go (TUG). A timed assessment of muscle function and mobility. It 
measures the time that an individual takes to rise from a chair, walk three meters, turn around, 
walk back to the chair, and sit down (Podsiadlo & Richardson, 1991). 
Gaps in Nursing Knowledge 
 
The relationship of self-efficacy for exercise, depression, and social support on muscle 
mass, strength, and function in older adults, particularly among RCACs residents, cannot be 
reasonably inferred from the existing literature. Although some risk factors such as nutrition and 
physical activity have been examined in several studies (Alexandre et al., 2014; Figueiredo et al., 
2014; Kim et al., 2011; Landi et al., 2012; Lau, Lynn, Woo, Kwok, & Melton, 2005; Lee et al., 
2007; Santos et al., 2015; Senior, Henwood, Beller, Mitchell, & Keogh, 2015; Tasar et al., 2015; 
Volpato et al., 2014; Yalcin et al., 2015), other potential risk factors have received less attention, 
particularly self-efficacy for exercise, depression, and social support. Limited studies have been 
previously conducted at nursing homes (Landi et al., 2012; Senior et al., 2015; Tasar et al., 
2015); however, it is not clear whether the results of these studies can be generalized to RCACs 
residents. To the best knowledge of the author, there is no nursing study that has yet examined 
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the relationship between the aforementioned cognitive and psychosocial factors and sarcopenia 
in older adults living in RCACs. In addition, although the most current literature explores the 
relationship between a few potential risk factors and sarcopenia in older adults, previous studies 
have lacked a theoretical framework or conceptual model to guide their research design and 
methodology.  
Furthermore, measures of ADL are not useful to identify the modifiable functional 
impairments and limitations that contribute to disability (Gibson et al., 2010; Giuliani et al., 
2008). One study found that most of the RCACs residents who were reportedly independent in 
ADL they had substantial mobility problems based on actual functional performance (Giuliani et 
al., 2008). However, most studies on RCACs residents in the United States still report general 
data about functional ability such as ADL without reporting benchmarks for functional data of 
this population (Giuliani et al., 2008; Roberts et al., 2013). There is limited knowledge about the 
muscle function characteristics of RCACs residents that based on muscle function measures. In 
addition, using a new technology such as MM to obtain precise measure of muscle function and 
benchmarks for functional data in older adults is important (Buehring et al., 2010; Rittweger et 
al., 2004). However, there is paucity of data comparing MM with other widely used traditional 
muscle function tests in older adults (Buehring et al., 2015; Rittweger et al., 2004; Siglinsky et 
al., 2015). This study will fill these gaps.   
Study Purpose 
 
The purpose of this dissertation study is threefold: 1) to describe the characteristics of 
muscle mass, strength, and function in older adults living in RCACs; 2) to determine, after 
controlling for pain, whether there is a difference in muscle mass, strength, and function among 
older living in RCACs based on self-efficacy for exercise, depression, and social support levels; 
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and 3) examine the convergent validity of MM parameters with widely used traditional muscle 
function tests (SPPB, TUG, and grip strength).  
Research Questions and Hypotheses 
 
The research questions that will be addressed in this study include: 
1) What are the self-efficacy for exercise, depression, social support of older adults living in 
RCACs? 
2) What are the muscle mass, strength, and function of older adults living in RCACs? 
The hypotheses for this study include: 
1) Participants with high self-efficacy for exercise will have greater muscle mass, strength, 
and function than participants with low self-efficacy for exercise. 
2) Participants who do not have depression will have greater muscle mass, strength, and 
function than participants who have depression. 
3) Participants with high social support will have greater muscle mass, strength, and 
function than participants with low social support. 
4) Weight corrected jump power obtained by MM correlates well with other traditional 
muscle function and strength tests, including SPPB, TUG, and grip strength. 
 
The findings of this study could contribute to the design of a tailored, nurse-driven, 
multicomponent intervention that could minimize sarcopenia, prolong independent mobility, and 
delay LTC placement among RCACs residents. 
Contributions to Nursing and Innovation 
 
This study will add to the nursing knowledge by examining potential risk factors for 
sarcopenia that have not been studies in previous research among older adults living in RCACs. 
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It will also provide a better understanding of muscle mass, strength, and function characteristics 
in older adults by using sophisticated technology including MM and BIS. MM and BIS tools, 
along with other traditional measures, will be used to assess muscle function and muscle mass, 
respectively. This study is among the first to focus on using highly innovative technology to 
quantitatively measure health outcomes in nursing research. The National Institute of Nursing 
Research has emphasized extending nursing science through the integration of biological 
sciences and supporting and employing new innovative technologies for research questions and 
methods (National Institute of Nursing Research [NINR], 2011). New technology generates 
opportunities to nursing researchers to move the nursing field forward and optimize patients’ 
health outcomes. 
The preliminary findings of this study could help on how best to further expand our 
current understanding of factors associated with sarcopenia and unsuccessful aging. The finding 
could also inform researchers and policy makers on how to best develop, test, and implement a 
multi-component nurse-driven intervention that could improve muscle function, prevent 
disability, and delay LTC placement among RCACs residents, and subsequently decrease 
healthcare costs.  
Study Setting and Sample 
 
This study is a secondary data analysis using a cross-sectional design from a randomized, 
crossover design study that investigated the effect of semi-recumbent vibration therapy on 
muscle mass, strength, and function in older adults age 70 and older. Participants were recruited 
from a RCAC located in the Midwestern United States. Participants completed several 
questionnaires and tests including Self-Efficacy for Exercise (SEE) Scale, Geriatric Depression 
Scale (GDS), Lubben Social Network Scale (LSNS), muscle mass (body composition), two-leg 
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maximal countermovement jump, SPPB, TUG, and grip strength tests. This secondary data 
analysis provides further analyses, interpretations, conclusions, and knowledge from the primary 
study. The author of this dissertation was the primary coordinator for the primary randomized 
controlled trial study. He was responsible for all aspects of study conduct to include recruitment, 
consent, scheduling exercise sessions, and coordinating testing visits.  
Chapter Summary 
 
This chapter introduced the importance of identifying the associated factors for 
sarcopenia and understanding the functional characteristics of older adults living in RCACs. The 
Individual & Family Self-management Theory (Ryan & Sawin, 2009) was adapted as a 
theoretical framework for this dissertation study. Self-efficacy for exercise, depression, and 
social support are factors that could influence the development and progression of sarcopenia 
and disability in RCACs residents. This dissertation study will provide new knowledge about the 
relationship between these factors and sarcopenia, muscle function characteristics, and new 
technology to assess muscle function in older adults living in RCACs. This knowledge is 
important to develop new intervention to improve muscle outcome and functional status, and to 
delay long-term placement of older adults living in RCACs. 
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CHAPTER 2 
 
Introduction to the Chapter 
In this chapter of this non-traditional dissertation, two manuscripts are presented. The 
first manuscript is a literature review that discuss the current state of knowledge regarding the 
associated risk factors for sarcopenia in older adults. Several studies that explore the risk factors 
for sarcopenia in older adults are examined. The second manuscript presents Muscle 
Mechanography (MM) as a novel method that can be used to quantitatively assess muscle 
function in older adults. MM is presented as a safe and useful method that appears to have more 
precision and reliability than more commonly used muscle function tests.  
 
Section 2.1-Manuscript 1 
Risk Factors for Sarcopenia in Older Adults: A Review of Literature 
Introduction 
 
Sarcopenia is an important geriatric syndrome characterized by generalized and 
progressive reduction in muscle mass, strength, and function that is associated with aging (Cruz-
Jentoft et al., 2010). The reduction in muscle mass typically starts at the age of 40 years, where 
approximately 8% of muscle mass is lost per decade until the age of 70 years. The loss 
accelerates to reach 15% per decade after age 70 and this reduction negatively affects muscle 
strength and function (Grimby & Saltin, 1983). The reduction in muscle mass, strength, and 
function is one of the most common causes of declines in mobility and increases dependency in 
older adults. This reduction also significantly reduces the ability of older adults to perform 
activities of daily living (ADL) and increases the risk of fall, loss of bone mineral density, and 
fractures (Cruz-Jentoft et al., 2010). 
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The implications of sarcopenia in the older adults have been reported extensively in the 
literature. Due to the changes in muscle mass, strength, and function that accompany aging and 
that are related to many interrelated factors, older adults are at increased risk for accelerated 
muscle loss and weakness, which contributes to functional decline, physical disability, and loss 
of independence. This consequently leads to increased healthcare services utilization, 
institutionalization, and healthcare costs (Cruz-Jentoft et al., 2010; Janssen et al., 2004).  
Sarcopenia is highly prevalent among older adults in both genders worldwide (Cruz-
Jentoft et al., 2014; Janssen et al., 2004; Pagotto & Silveira, 2014). Estimates based on the 
prevalence of sarcopenia and on the World Health Organization population data suggest that 
more than 50 million of older adults are affected by sarcopenia, and the number is expected to 
increase to more than 200 million over the next 40 years (Bruyère et al., 2016). In 2000, the 
World Health Organization reported that the number of people around the world aged 60 years 
and older was around 600 million and the number is expected to rise to 1.2 billion by 2025 and 2 
billion by 2050 (Bruyère et al., 2016). In the United States, the number of individuals over 65 
years old is predicted to increase to over 70 million by 2030 due to two factors: longer life spans 
and aging baby boomers (Administration on Aging, 2012). Hence, the prevalence of sarcopenia 
and its negative outcomes among older adults and the healthcare system is expected to increase, 
which underscores the importance of sarcopenia diagnosis and prevention in older adults.  
Sarcopenia has many causes and can be observed in both young and older adults (Cruz-
Jentoft et al., 2010; Pagotto & Silveira, 2014). Sarcopenia can be classified into two categories: 
primary and secondary sarcopenia. Sarcopenia can be considered primary or age-related when no 
other causes are evident but aging itself. Secondary sarcopenia is the term used when one or 
more causes for changes in muscle mass and function are identified such as chronic illnesses, 
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malnutrition, cachexia, chronic inflammation, muscle disuse, and physical inactivity (Cruz-
Jentoft et al., 2014). The cause of sarcopenia in many older adults is multifactorial so that it may 
not be possible to describe each individual as having a primary or secondary sarcopenia. This 
situation is consistent with recognizing sarcopenia as a multi-faceted geriatric syndrome (Cruz-
Jentoft et al., 2010; Cruz-Jentoft et al. 2014; Landi et al. 2012).  
Whereas several mechanisms for the development of sarcopenia are well understood 
(e.g., hormonal alterations, protein synthesis, proteolysis, and endocrine issues), the role of 
cognitive factors (e.g., self-efficacy) and psychosocial factors (e.g., depression and social 
support) on the onset and progression of sarcopenia are currently poorly understood (Brady et al., 
2014; Campbell & Vallis, 2014; Goisser et al., 2015; Henwood et al., 2014). Understanding risk 
factors and mechanisms of action can potentially assist in identifying early markers for 
sarcopenia prevention. Identifying the modifiable risk factors for sarcopenia is pivotal to 
developing and implementing therapeutic interventions to reduce the negative consequences of 
sarcopenia including disability, institutionalization, falls, fractures, and death. While knowledge 
gaps remain, there is some evidence that several factors may contribute to the phenomenon of 
sarcopenia in older adults (Brady et al., 2014; Fielding et al., 2011; Goisser et al., 2015; 
Henwood et al., 2014).  
The purpose of this manuscript is to review the literature that describes the factors 
associated with sarcopenia in older adults. A search for relevant literature was conducted using 
the Cumulative Index to Nursing and Allied Health Literature (CINAHL), PubMed, and 
PsychInfo using keywords ‘sarcopenia’, ‘muscle mass’, ‘muscle strength’, ‘muscle function’, 
‘older adults’, ‘elderly’, ‘residential care apartment complexes (RCACs)’, ‘nursing homes’, ‘risk 
factors’, ‘psychosocial factors’, ‘cognitive factors’, ‘self-efficacy’, ‘depression’, and ‘social 
 23 
 
support’. A total of 172 articles were retrieved.  Inclusion criteria consisted of relevant, full-text 
English language research studies in older adults aged 60 years and older, resulting in 21 articles 
to be reviewed. 
Methods 
 
The databases searched for relevant literature were CINAHL, PubMed, and PsychInfo. 
Keywords for this preliminary search included ‘sarcopenia’, ‘muscle mass’, ‘muscle strength’, 
‘muscle function’, ‘older adults’, ‘elderly’, ‘residential care apartment complexes (RCACs)’, and 
‘nursing homes’. Over 3,400 articles were identified. Additional terms were used to refine the 
search including keywords ‘risk factors’, ‘psychosocial factors’, ‘cognitive factors’, ‘self-
efficacy’, ‘depression’, and ‘social support’. The search was limited to relevant, English 
language papers published between 2000 and 2016. Due to the paucity of studies among older 
adults living in RCACs, the criteria for considering studies were broadened to include studies 
that identified associated factors for sarcopenia in community-dwelling older adults, assisted 
living facility residents, and nursing home residents aged 60 years and older. This refined search 
resulted in 172 articles of which the titles and abstracts were screened for inclusion criteria. 
Reference lists of relevant articles were screened for other potentially eligible studies. A total of 
21 studies met the inclusion criteria and were extracted for review. The outcomes obtained from 
a review of the literature are illustrated in Appendix A. 
Results 
 
Physical Activity 
 
Several correlational, cross-sectional studies explored the relationship between physical 
activity and sarcopenia in community-dwelling older adults (Alexandre et al., 2014; Castillo et 
al., 2003; Figueiredo et al., 2014; Gianoudis et al., 2014; Lee et al., 2007; Senior et al., 2015; 
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Volpato et al., 2014), and nursing home residents (Landi et al., 2012; Senior et al., 2015; Tasar et 
al., 2015; Yalcin et al., 2015). The International Physical Activity Questionnaire-Short Form, 
Barthel Index of Activities of Daily Living, and Physical Activity Scale of the Elderly were used 
as tools to assess physical activity level.  
Most of these studies show a negative association between physical activity and 
sarcopenia and that sarcopenia is less likely to be present among older adults with high levels of 
physical activity. The presence of sarcopenia was also inversely associated with involvement in 
daily leisure physical activities. In addition, Hsu and colleagues conducted a correlational, cross-
sectional study in a veterans retirement community and found that low level of ADL and 
physical dependence were significantly associated with sarcopenia in older men (Hsu et al., 
2014). One correlational, cohort, longitudinal study also revealed that low physical activity is 
significantly associated with the development of sarcopenia in community-dwelling older adults. 
The results of the protective effect of physical activity indicate a need for intervention and that 
increasing physical activity could be beneficial in preventing sarcopenia (Yu et al., 2014). 
However, only a few studies showed no significant association between physical activity 
level and sarcopenia among community-dwelling older adults (Volpato et al., 2014; Alexandre et 
al., 2014), and nursing home residents (Tasar et al., 2015; Yalcin et al., 2015). However, the 
results of these studies have some limitations including selective healthy individuals and limited 
number of individuals with sarcopenia which may led to small statistical power and increased the 
probability of type II error.  
Although resistance exercise and weight training are effective countermeasures to 
sarcopenia in older adults, vigorous exercise is not always required and moderate physical 
activity carried out as part of everyday activities and regular leisure activities (e.g., walking, 
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gardening, and dancing) seem to be enough to reach considerable benefits among older adults 
(Figueiredo et al., 2014; Landi et al., 2010). In their correlational, cross-sectional study, Lee and 
colleagues reported that the Physical Activity Scale for the Elderly (PASE) score — a detailed 
record about physical activity involved in recreational, household, and social/voluntary work in a 
week time period — showed a significant association between physical inactivity and low 
appendicular muscle mass, which is an essential component of sarcopenia (Lee et al., 2007). In 
addition, a correlational, cross-sectional study examined the relationship between sedentary 
behaviors and musculoskeletal health and function in community-dwelling older adults found 
that greater overall sitting time is associated with an increased risk of sarcopenia (Gianoudis et 
al., 2014). Likewise, Senior and colleagues in their correlational, cross-sectional study found that 
setting time was predictive of sarcopenia in nursing home residents (Senior et al., 2015). 
Self-efficacy. Although physical activity recommendations for older adults include both 
aerobic exercise and resistance-training, estimates indicate that only 51.1% and 21.9% of older 
adults meet the aerobic and resistance-training guidelines, respectively (Brady & Straight, 2014). 
Yet, most of older adults do not meet the recommended physical activity guidelines and engage 
in a sufficient volume of physical activity to promote health outcomes. Researchers assert that an 
important aspect very rarely addressed so far in sarcopenia research is the influence of self-
efficacy (Brady et al., 2014; Goisser et al., 2015). An older adult with or without sarcopenia 
might not be easily integrated into a group-based exercise program and maybe prone to a 
sedentary lifestyle due to lack of self-efficacy. As research has demonstrated in behavioral 
change interventions, the role of self-efficacy is an important factor and is considered one of the 
strong predictors for the level of physical activity in older adults (Goisser et al., 2015). However, 
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no studies found that examined the association between self-efficacy and sarcopenia in older 
adults. 
Nutritional Status 
 
Multiple correctional, cross-sectional studies have explored the association between 
nutritional status and sarcopenia in community-dwelling older adults (Alexandre et al., 2014; 
Figueiredo et al., 2014; Gariballa & Alessa, 2013; Kim et al., 2011; Lau et al., 2005; Lee et al., 
2007; Santos et al., 2015; Volpato et al., 2014) and nursing home residents (Landi et al., 2012; 
Senior et al., 2015; Tasar et al., 2015; Yalcin et al., 2015). Body mass index (BMI) and the Mini 
Nutritional Assessment (MNA) tool were the two main methods used to evaluate nutritional 
status.  
Most of the studies reported a negative association between malnutrition/BMI and 
sarcopenia (Alexandre et al., 2014; Figueiredo et al., 2014; Kim et al., 2011; Landi et al., 2012; 
Lau et al., 2005; Lee et al., 2007; Santos et al., 2015; Tasar et al., 2015; Yalcin et al., 2015). Hsu 
et al. (2014) also reported that low BMI was significantly associated with sarcopenia in older 
men living in a veterans retirement community. One correlational, retrospective, longitudinal 
study showed that malnutrition is significantly associated with sarcopenia in community-
dwelling older adults and that high BMI is a predictor of sarcopenia (Murphy et al., 2013). Yu 
and colleagues conducted a correlational, cohort, longitudinal study and reported that low BMI is 
significantly associated with sarcopenia in community-dwelling older adults (Yu et al., 2014).  
This review shows that sarcopenia is less likely to be present among participants who 
have a normal BMI, as well as an appropriate BMI is associated with higher muscle mass, 
muscle strength, and physical performance. In addition, older adults with sarcopenia are dem-
onstrated to have a significantly lower BMI and poorer nutritional status than those without 
 27 
 
sarcopenia. A low BMI serves as an independent predictor of sarcopenia in both community-
dwelling older adults and nursing home residents (Alexandre et al., 2014; Landi et al., 2012; 
Murphy et al., 2013; Yu et al., 2014). These results may have implications for development of 
interventions to improve nutritional status and improve muscle outcomes.  
Depression 
 
Several cross-sectional studies explored the association between depression and 
sarcopenia in community-dwelling older adults (Alexandre et al., 2014; Byeon, Kang, Kang, 
Kim, & Bae, 2016; Gariballa & Alessa, 2013; Han et al., 2016; Kim et al., 2011; Lee et al., 2007; 
Volpato et al., 2014), nursing home residents (Senior et al., 2015), and older men living in a 
veterans retirement community (Hsu et al., 2014). The GDS and the Center for Epidemiologic 
Studies Depression (CESD) scale were used to evaluate depression among the participants.  
A positive association has been found between depression and sarcopenia in older adults, 
and depression was less likely to be present among older adults who have higher skeletal muscle 
mass (Gariballa & Alessa, 2013; Hsu et al., 2014; Kim et al., 2011). In a correctional, cross-
sectional study among older men and women, individuals with self-reported depression or those 
taking antidepressants had lower muscle mass than those free of depression or antidepressant 
medications use (4.2 % lower in men and 3.7 % lower in women) (Kim et al., 2011). In another 
correlational, cross-sectional study included hospitalized patients aged 65 years and older, those 
identified with sarcopenia were more likely to be older, suffer from depression, and have a 
longer length of hospital stay (Gariballa & Alessa, 2013). 
In contrast, the association between depression and sarcopenia was not detected in other 
studies. For instance, in a recent study included multiple age groups (20-39, 40-59, and ≥60 
years) (N= 7,364), sarcopenia group did not have a higher prevalence of depression or depressive 
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symptoms compared to the non-sarcopenia group, and all age groups showed no significant 
association between depression and sarcopenia (Byeon et al., 2016). Another correlational, cross-
sectional study included 1,149 Brazilian community-dwelling older adults found no association 
between depression and sarcopenia (Alexandre et al., 2014). Other correlational, cross-sectional 
studies reported no association between depression and sarcopenia in community-dwelling older 
adults (Han et al., 2016; Lee et al., 2007; Volpato et al., 2014). Only one correlational, cross-
sectional study conducted in a nursing home and found no relationship between depression and 
sarcopenia (Senior et al., 2015). Therefore, the literature has shown inconsistent results and 
conflicting reports about the association between depression and sarcopenia. Further studies are 
needed to assess the relationship between depression and sarcopenia among older adults. 
Cognitive Impairment 
 
Cognitive impairment has been linked to poor functional status and sarcopenia in older 
adults. Cognitive impairment commonly leads to sedentary lifestyle, bed rest, and malnutrition, 
which could trigger excessive muscle loss in older adults (Hsu et al., 2014). Cognitive 
impairment also causes neuronal changes in the central nervous system which alters the levels 
and activity of neurotransmitters, and consequently leads to a decrease in the motor units and the 
ability to maintain muscle activation (Walston et al., 2006).  
Several correlational, cross-sectional studies explored the association between cognitive 
function and sarcopenia in community-dwelling older adults (Alexandre et al., 2014; Volpato et 
al., 2014), nursing home residents (Landi et al., 2012; Senior et al., 2015; Yalcin et al., 2015), 
and in older men living in a veterans retirement community (Hsu et al., 2014). The Mini-Mental 
State Examination and Cognitive Performance Scale were the most common methods used to 
evaluate the cognitive function among the participants. Two studies showed that cognitive 
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impairment is associated with sarcopenia in older adults (Alexandre et al., 2014; Hsu et al., 
2014). However, other studies showed no association between cognitive function and sarcopenia 
(Landi et al., 2012; Senior et al., 2015; Volpato et al., 2014; Yalcin et al., 2015). Yu and 
colleagues also found no significant associations between cognitive impairment and incident 
sarcopenia (Yu et al., 2014). Therefore, supporting data are still scarce and controversial, and the 
association between cognitive function and sarcopenia needs further investigation. 
Social Support 
 
Strong social support and high social participation are often considered in discussions 
about healthy aging. Researchers underscore the importance of understanding these factors and 
to identify means through which social support and social participation might be maintained, 
particularly among older adults (Cruz-Jentoft et al., 2010; Wallace et al., 2015; Yeom et al., 
2008). Social support is a common risk factor associated with quality of life among older adults. 
Poor social support has negative impacts on physical, cognitive, and mental wellness, as well as 
on morbidity and mortality (Cruz-Jentoft et al., 2010; Wallace et al., 2015). Nonetheless, no 
studies were found that explore the relationship between social support and sarcopenia in older 
adults.  
Only one study was found that examined the association between social participation and 
lower extremity muscle strength and gait speed in Americans aged 50 years and older (Warren, 
Ganley, & Pohl, 2016). The study revealed a significant association between social participation 
and gait speed among older adults who aged 65 years and older. Older adults with low social 
participation had three times higher odds of slower walking speed compared with those without a 
reported limitation with social participation (OR = 3.1; 99% CI [1.5–6.2]). The social 
participation was also significant with lower extremity strength and self-reported limitation in 
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those 65 and older. These older adults had a significantly three times higher odds of being weak 
compared with strong (OR = 3.5, 99% CI [1.3–9.9]) (Warren et al., 2016). 
Smoking and Alcohol Consumption 
 
Multiple correlational, cross-sectional studies explored the relationship between smoking 
status and sarcopenia in community-dwelling older adults (Alexandre et al., 2014; Castillo et al., 
2003; Figueiredo et al., 2014; Gabrilla & Alessa, 2013; Han et al., 2016; Lau et al., 2005; Lee et 
al., 2007; Martins, Bôas, & McLellan, 2016), and nursing home residents (Tasar et al., 2015). 
Self-reported questionnaires were used to assess smoking status among the participants. Smoking 
was reported as a risk factor for sarcopenia (Alexandre et al., 2014; Castillo et al., 2003; 
Figueiredo et al., 2014; Lee et al., 2007; Martins et al., 2016; Tasar et al., 2015). Alexandre et al. 
(2014) stated that smoking may reduce the ability of the already suffering system to obtain 
muscular energy, which may cause muscle fatigue and subsequently increase the protein 
catabolism that can reduce muscle mass and function (Alexandre et al., 2014). One correlational, 
longitudinal study showed no significant association between smoking status and sarcopenia in 
community-dwelling older adults (Murphy et al., 2013).  
Other studies examined the association between alcohol consumption and sarcopenia 
using self-reported questionnaire in community-dwelling older adults (Castillo et al., 2003; 
Gabrilla & Alessa, 2013; Lau et al., 2005; Lee et al., 2007; Han et al., 2016), and nursing home 
residents (Tasar et al., 2015). The results did not support alcohol consumption as a risk factor for 
sarcopenia. However, only one study showed a significant association between daily drinking 
and sarcopenia in women, suggesting that chronic consumption may promote loss of muscle 
mass and strength in old age (Han et al., 2016). 
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Other Factors 
 
A few correlational, cross-sectional studies explored the relationship between chronic 
illnesses and pain and sarcopenia. Several studies revealed that cerebrovascular disease, 
hypertension, osteoarthritis, and diabetes are factors associated with sarcopenia in older adults 
(Han et al., 2016; Landi et al., 2012; Lee et al., 2007). A correlational, longitudinal study also 
showed that stroke is associated with sarcopenia (Yu et al., 2014). Pain was also found to be a 
risk factor for sarcopenia in older adults. Murphy et al. (2013) assessed muscle mass, gait speed, 
and grip strength seven times over 9 years and found that pain is a predictor of transition from 
the normal state toward sarcopenia in older adults. The result may reflect avoidance of physical 
activity due to pain-related fear, as well as pain may indicate inflammation that contributes to 
muscle loss.  
Critique of the Literature 
 
The examined literature showed that the majority of the studies were conducted among 
community-dwelling older adults, whereas only a few studies focused on older adults living in 
nursing homes. Only one study conducted among older men living in a veterans retirement 
community and no studies found among assisted living facilities residents. Most of the studies 
were correlational with a cross-sectional design, which limits the ability to clarify any cause-
effect relationships between sarcopenia and its associated factors. Detailed descriptions of the 
participants including sample size, age, gender, and demographic location from which the 
participants were recruited were discussed. However, many studies did not report how the effect 
size was justified.  
The inclusion and exclusion criteria were clearly presented in most of the studies. 
However, several studies potentially introduced selection bias by excluding older adults living in 
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institutions and those with mobility difficulties (e.g., individuals using walker), and representing 
only healthier, more physically active, and more educated individuals from the general 
population (Alexandre et al., 2014; Gariballa & Alessa, 2013; Lee et al., 2007; Murphy et al., 
2013; Tasar et al., 2015; Volpato et la., 2014; Yalcin et al., 2015; Yu et al, 2014). Thus, it cannot 
be said that the sampling is necessarily representative of the overall older adult population. These 
limitations may also hinder the ability to detect associations between potential risk factors and 
sarcopenia. Interestingly, most of the studies were found on sarcopenia and its associated factors 
were current and published in the past 5 years, which indicates that interest in sarcopenia among 
older adults is growing among members of the scientific community and more research is needed 
in this area. 
The majority of the measures and data collection procedures were clearly defined and 
described in the reviewed studies. However, the studies have several methodological issues. 
First, most of the studies have used traditional muscle function tests (e.g., gait speed, timed-up-
and-go (TUG), and chair rise tests) to assess muscle function. These traditional measures have 
important limitations. These limitations include pass/fail determinations and timing variability 
resulting from examiner subjectivity. Older adults with significant disability may not be able to 
perform chair-rise or TUG test. Another limitation is that the traditional chair-rise test requires 
maximal power (watts) but is reported in seconds (Taani et al., 2017). 
Second, the use of bioelectrical impedance spectroscopy (BIS) to measure muscle mass 
may lead to measurement errors because of the dehydration problems that can be observed in 
older adults. Decreasing the total body water may result in an underestimation of body fat and an 
overestimation of fat-free mass (Yamada et al., 2013). However, BIS is inexpensive, easy to use, 
reproducible, and considered a portable alternative to dual-energy X-ray absorptiometry (DXA) 
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(Yamada et al., 2013). Measure muscle mass in older adults using DXA is not feasible and BIA is 
a more practical method to use in large samples. Finally, one study did not find an association 
between physical activity and nutritional status and sarcopenia (Volpato et al., 2014). This 
unexpected result may due to misclassification in the self-report assessment of physical activity 
level and nutritional intake. 
Discussion 
 
Sarcopenia is considered a main cause for impaired physical function, dependency, and 
decreased quality of life (Morley, 2012). This underscores the importance of identifying the risk 
factors associated with sarcopenia and developing effective preventative interventions. This 
review shows that physical inactivity and malnutrition are risk factors for sarcopenia in older 
adults. These two factors were common across most of the studies. Although self-efficacy for 
exercise is considered one of the strong predictors for the level of physical activity in older adults 
(Goisser et al., 2015; Brady et al., 2014), the impact of self-efficacy has been rarely addressed in 
relation to sarcopenia and none of the studies examined the existence of such relationship.  
Several studies showed that older adults with sarcopenia were more frequently diagnosed 
as malnourished than older adults without sarcopenia. Maintaining proper nutrition status and 
BMI along with adequate protein intake play a major role in preventing and managing sarcopenia 
in older adults (Alexandre et al., 2014; Landi et al., 2012; Yu et al., 2014). These results can be 
significantly important for conducting further research and designing effective interventions to 
improve nutritional status and prevent sarcopenia. 
Studies shows that depression and cognitive impairment are inconsistently associated 
with sarcopenia. Limited studies reported a significant relationship between these two factors 
and sarcopenia (Alexandre et al., 2014; Hsu et al., 2014; Gariballa & Alessa, 2013; Kim et al., 
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2011). Depression and cognitive impairment may lead to malnutrition and sedentary lifestyle, 
which may contribute to muscle loss and development of sarcopenia (Hsu et al., 2014; Kim et al., 
2011). However, evidence showed that the relationship between depression and cognitive 
impairment and sarcopenia is still poorly understood and further research is needed in this area. 
Although researchers emphasized the importance of social support in the context of aging 
(Cruz-Jentoft et al., 2010; Wallace et al., 2015; Warren et al., 2016; Yeom et al., 2008), no 
studies explored the relationship between social support and sarcopenia. Furthermore, limited 
evidence was reported about the relationship between smoking status, alcohol consumption, pain, 
and chronic illnesses and sarcopenia. While limited studies in this review showed a significant 
association between smoking status and pain and sarcopenia, none of the studies showed a 
significant association between alcohol consumption and sarcopenia.  
Conclusion and Gaps in Knowledge 
 
This review revealed that the relationship of self-efficacy for exercise, depression, and 
social support on muscle mass, strength, and function in RCACs residents is poorly understood. 
Many studies have focused on common factors including physical activity and nutrition status 
and limited or no studies were found that addressed other potential factors including self-
efficacy, depression, and social support. Several studies have also focused on identifying the risk 
factors for sarcopenia in community-dwelling older adults and no studies indicate that attention 
has been focused on RCACs residents. 
To gain better understanding of the risk factors for sarcopenia among older adults living 
in RCACs, more studies need to be conducted in this at-risk group. Knowledge of this at-risk 
group is important to develop tailored interventions to prevent sarcopenia and its negative health 
consequences. Such interventions may also assist in improving or maintaining functional status 
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and preventing or delaying transfer to more restrictive living environments, and consequently 
enhancing quality life of older adults and decreasing use of expensive healthcare services.  
In addition, most the studies have used traditional muscle functions tests to assess muscle 
function among the participants. These tests have several limitations and more precise 
measurements of muscle function in older adults are needed. More research is need to address 
these gaps in the literature; to gain better understanding of the risk factors for sarcopenia in 
RCACs residents and provide knowledge about the muscle function characteristics of this at-risk 
group of older adults. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 36 
 
Section 2.2-Manuscript 2 
 
Manuscript 2: Muscle Mechanography: A Novel Method to Measure Muscle Function in 
Older Adults 
Introduction 
 
Assessing muscle function in older adults has become an important topic in the field of 
geriatric research. Aging is associated with changes in body composition and functional 
capability, including a reduction in muscle mass and muscle function (Morley, 2012). These age-
related reductions have been named sarcopenia (Fielding et al., 2011). Recent estimates indicate 
that up to 45% of older adults in the United States experience sarcopenia, depending on which 
population is studied and which definition is used (Janssen et al., 2004). Older adults with 
sarcopenia are at greater risk for falls, fractures, and head injuries (Buehring et al., 2010; Morley, 
2012). Compromised muscle function in older adults was found to be an independent predictor 
of increased use of long-term care facilities, hospitalization, disability, and mortality (Clark & 
Manini, 2010; Hirani et al., 2015; Landi et al., 2013). 
Assessment of sarcopenia requires measurement of muscle function. Key physical units 
necessary to quantify muscle function include: force (Newtons [N]), velocity (m/s), and power 
(watts [W]). Muscle force relates to the force exerted to get the body moving, or the direct 
muscle forces imparted to the skeleton during movement. Common tests assessing muscle force 
are grip strength or knee extensor strength. These tests require a maximal muscle contraction to 
create a peak force. Muscle force is one of the primary regulators of bone mass and an important 
determinant of bone and joint health in older adults. Muscle force is strongly correlated with 
bone strength, bone size, total bone area, and femoral neck bone mineral density (Hardcastle et 
al., 2014; Pojednic et al., 2012; Rantalainen et al., 2009; Runge & Hunter, 2006). Muscle 
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velocity (or movement velocity) is the rate of motion (speed) in a specific direction. The best 
example of a test measuring velocity is the 4-m walk to assess gait speed. Velocity (e.g., gait 
speed) slows with aging and is a key component in the onset of functional impairments in older 
adults. 
Muscle force and velocity are significant determinates of power production and 
functional task performance in older adults (Pojednic et al., 2012). Muscle power is defined as 
the ability to generate as much force as possible and as quickly as possible. It is calculated as the 
product of force and velocity. Thus, altered neural or muscular ability affecting either factor 
(force or velocity) will contribute to declines in power and potentially physical function 
(Pojednic et al., 2012). Examples of tests measuring power are the chair-rise test and two-leg 
maximal countermovement jumps. Muscle power is a valuable measure for identifying age-
related physical impairments and strongly correlates with physical capability, mobility, the risk 
of falling, and sarcopenia (Caserotti, Aagaard, Simonsen, & Puggaard, 2001; Runge & Hunter, 
2006; Rittweger et al., 2004; Siglinsky et al., 2015; Singh et al., 2014). Leg power is often 
corrected for body weight (W/kg). 
Several traditional muscle function measures have been developed, validated, and used to 
assess muscle function in older adults (Siglinsky et al., 2015). Among these, gait speed is one of 
the most frequently used methods. It is measured as the time taken to walk 4 m or another 
distance achieved during a 2-minute timeframe. Gait speed is a predictor for falls, fractures, 
hospitalization, caregiver need, and mortality among older adults (Montero-Odasso et al., 2005; 
Studenski et al., 2011). The chair-rise test is measured by the time required to rise from a chair 
five times without using its arms. After first assessing if the individual is able to rise once 
successfully, he/she will be asked to rise from a chair five times and time to complete the five 
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chair rises will be recorded. Repeated chair-rise performance is strongly related to fall and hip 
fracture risk among older adults (Cawthon et al., 2008). The grip strength test assesses muscle 
strength using a hand-grip dynamometer. Grip strength is associated with important clinical 
measures, including disability, length of hospital stay, postoperative complications, and mortality 
in older adults (Bohannon, 2015). Low grip strength is also associated with various causes of 
death, including myocardial infarction, stroke, fall, and fracture (Leong et al., 2015). 
However, many of the traditional tests have limitations: they often cannot be used over a 
wide range of performance levels and have drawbacks for testing older adults who have very 
high or low functional ability. For example, self-selected usual gait speed has a ceiling effect 
because at some point the individual is walking at a faster pace than his/her usual pace or even 
jogging/running. The chair-rise test has a floor effect because individuals who cannot rise from 
the chair cannot be measured. Often these measures only examine particular aspects of muscle 
function (e.g., balance, power, force) and few provide a quantitative measure (e.g., force, 
velocity, power). For example, the traditional chair-rise test requires maximal power (W) but is 
reported in seconds (Buehring et al., 2013; Puthoff, 2008; Siglinsky et al., 2015). Other 
limitations of these tests include dichotomous (pass/fail) determinations and being prone to 
human errors as the final results depend on the times taken by individual examiners (Buehring et 
al., 2013; Siglinsky et al., 2015). 
Therefore, quantitative methods for the precise measurement of muscle function in older 
adults over a broad range of performance is desirable. The National Institute of Nursing 
Research has emphasized extending nursing science through the integration of biological 
sciences and supporting and employing new innovative technologies for research questions and 
methods (NINR, 2011). These technologies should include methods to optimally assess muscle 
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function in older adults. Muscle mechanography is an innovative technology that quantitatively 
assesses muscle function parameters in older adults using a ground reaction force platform 
(GRFP). The purpose of the current article is to introduce muscle mechanography as a method to 
assess muscle function in older adults. The review covers the mechanism of muscle 
mechanography, different types of tests, parameters that can be obtained by using muscle 
mechanography, measurement procedures, reproducibility, and safety. 
Muscle Mechanography 
 
Muscle mechanography can quantitatively assess muscle function (force, velocity, power, 
center of gravity/sway) using a GRFP. Movements that can be measured include heel rise, chair 
rise, hopping, jumping, and static balance positions (e.g., semi-tandem or tandem stance). A 
variety of GRFP systems have been used in research settings (Buehring et al., 2010; Matheson et 
al., 2013; Rantalainen et al., 2010; Rittweger et al., 2004; Singh et al., 2014). One of the most 
commonly used systems is the Leonardo Mechanograph®. 
Principle of Measurement 
 
The Leonardo Mechanograph GRFP comprises two symmetrical left- and right-sided 
force plates, which measure and quantify any asymmetries in individuals' physiological 
movements. A mass (e.g., body weight) creates a vertical ground reaction force on the plates, 
which elicits changes in electrical resistance in the GRFP's sensors that are proportional to the 
exerted force. The voltage changes are measured at a frequency of 800 Hz by four strain gauge 
force detectors located in each force plate (eight total force sensors). The collected voltage 
reading is transferred via a USB 2.0 connection to a personal computer running the Leonardo 
Mechanography software (Binkley & Specker, 2008; Matheson et al., 2013; Rittweger et al., 
2004; Veilleux & Rauch, 2010). From the measured voltage and changes in voltage over time, 
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the software can calculate other muscle function parameters, such as velocity and power. Several 
software versions are available and the most recent includes reference data for individuals ages 3 
to 99 years. 
Muscle Function Parameters Obtained Using Muscle Mechanography 
 
Unlike traditional muscle function tests, muscle mechanography directly measures the 
applied force vector and calculates measures of force, velocity, power, jump height, and sway 
(i.e., the change of the center of gravity during a balance test) (Buehring et al., 2010; Matheson 
et al., 2013; Rittweger et al., 2004). The Leonardo system also reports the Esslinger Fitness 
Index, an age- and sex-adjusted measure of power assessed during countermovement jumps. 
Operational definitions of the variables available through Leonardo mechanography are 
presented in the Table 1. 
 
Table 1 
Operational Definitions of the Variables Available Through Muscle Mechanography 
Variable Definition 
Force 
 
 
 
 
Velocity 
 
 
Power                                     
 
 
 
 
 
Esslinger Fitness 
Index (EFI) 
 
 
Jump height 
The total force exerted on the platform to get the body moving, which 
also causes acceleration. Force is exerted by movements. Force is 
calculated by multiplying body’s mass with its acceleration. Force 
(Newton) = mass (kg) x acceleration (m/s). 
 
Velocity is the rate of motion (speed) in a specific direction. It is 
calculated by integrating acceleration over time. 
 
Power is a necessary parameter to measure movement. Movement is the 
action of force along a specific distance in a certain time, which is 
measured as power. Power is also used to describe the rate at which 
energy is used. It is calculated by multiplying force and velocity. 
Power=force x distance/ time = force (N) x velocity (m/s). 
 
This is the performance of the movement. The EFI represents the 
maximum jump power relative to body weight for one’s age (ages 3 to 
99 years) and gender-matched reference population. 
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 Jump height is defined as the displacement of the body’s center of 
gravity. Integration of velocity over time results in displacement of 
center of gravity/jump height. 
 
 
Measurement Procedures 
 
Platform Quality Assurance 
 
Although no standardized procedure exists, it is the current authors' recommendation that 
the platform should be calibrated at least weekly to assure accuracy and precision of the static 
properties before performing any tests. In addition, it should be calibrated every time it is moved 
from one location to another. Three 20-kg Troemner cast iron grip handle weights were used for 
calibration in the current authors' studies. These weights are stacked in one corner of the platform 
and the measurement of the weight is recorded. This process is repeated for each of the other 
three corners. In addition, two weights are placed side by side in the middle of the platform with 
a third weight placed on top to obtain a central measurement. If any measurements are outside of 
the ±0.5-kg limit, recalibration is needed. 
Test Procedures 
 
Several tests and movements can be performed on the GRFP. All tests are generally easy 
to understand as they are natural movements that most individuals have performed throughout 
their lives (e.g., rising on the toes, rising from a chair, hopping/jumping). However, it is 
recommended that participants receive standardized instructions and that the tests be 
demonstrated by a trained staff member. In addition, older adults should wear a gait belt while 
performing tests and at least two staff members should be present to ensure the individual's 
safety. Staff should be ready to assist the participant who is wearing a gait belt in case he/she 
loses balance (Figure 3). 
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Figure 3. Example of Older Adult Performing a Countermovement Jump under supervision of 
two trained staff members. 
 
Heel-rise test. The main outcomes of this test are velocity and power. The test comprises 
heel rises with the goal of achieving the maximum speed of their upward movement. After 
standing still on the force platform, participants should be instructed to rise on their tiptoes by 
lifting their heels from the force platform as quickly as possible after hearing a single-tone beep 
(Veilleux & Rauch, 2010). A double-audible tone indicates the end of the test. Participants are 
asked to perform three heel raises and the heel raise with the greatest height is used for analysis. 
This test is useful for older adults who have a degree of functional disability that limits their 
ability to participate in the jump and chair-rise tests. 
Chair-rise test. The major outcomes of this test are force, velocity, and power. In 
addition, this test evaluates a movement that is highly relevant in everyday life (Veilleux & 
Rauch, 2010). A specific bench is installed on the force plate for the purpose of this test. After 
sitting on the bench with feet on the ground, participants are instructed to cross their arms over 
their chest, then stand up straight and sit down again as fast as possible. If participants rise 
successfully, they are instructed to repeat this five times as quickly as possible. These are exactly 
the same instructions as for the traditional chair-rise test, but muscle power is reported instead of 
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time. The rise with the highest maximum power, or an average of several rises (three to five), is 
analyzed. 
Single two-legged countermovement jump. This test has been extensively used among 
older adults in research settings (Buehring et al., 2010; Matheson et al., 2013; Rittweger et al., 
2004; Runge et al., 2004; Siglinsky et al., 2015; Singh et al., 2014). The main outcome of this 
test is power (usually body weight corrected power [W/kg] is reported), but velocity and force 
can also be examined. To perform the test, participants stand on a platform, with a foot on each 
side, as still as possible. After standing still on the platform for at least 2 seconds, participants' 
body weight is recorded. Participants should be instructed to perform the jump as quickly and as 
high as possible, using both legs after hearing a single-tone beep. Participants should stand up 
straight and remain still after landing on the platform for at least 2 seconds until a double-tone 
beep indicates the end of the test (Buehring et al., 2010; Veilleux & Rauch, 2010). Participants 
can jump freely, without any arm movement restrictions (Figure 4). This procedure is repeated 
several times, with the goal to get three countermovement jumps deemed valid by the software. 
Participants should be given time to rest and recover between jumps. Depending on the 
participant's ability to lift off the platform completely and stand still before and after the jump, it 
might not always be possible to record three valid jumps. The jump with the greatest height is 
selected for analysis. 
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Figure 4. Sequence of A Countermovement Jump. (A) Before the jump, the participant stands in 
an upright position on the force platform as still as possible; (B) The participant squats as quickly 
as possible before the jump; (C) The participant jumps as high as possible; (D) The participant 
begins the smooth landing stage; and (E) The participant stands up straight and as still as 
possible. 
 
Serial one- or two-legged jumps (hopping). Although this type of test measures force, 
velocity, and power, it is used to assess maximal jump force, which is correlated with bone 
strength, bone size, bone strength indices, total bone area, and tibial strength strain index 
(Hardcastle et al., 2014; Rantalainen et al., 2009; Runge & Hunter, 2006). Participants are 
instructed to hop on one forefoot or both forefeet with their knee almost straight and without 
touching the ground with their heel. Participants should hop 10 times. The software detects and 
eliminates hops if heels hit the ground; the hop with the highest force is used for analysis 
(Veilleux & Rauch, 2010). 
Balance assessment/measurement of sway. This test can be used to assess balance, 
coordination, and fall-risk assessment in older adults. Participants try to stand as still as possible 
in a comfortable upright position with both arms hanging free and a foot on each side of the 
platform for a specific period of time (e.g., 10 seconds). Various feet positions and open or 
closed eyes, such as used by the Romberg, semi-tandem, and tandem stands, can be chosen to 
increase difficulty. Instructions for these foot positions are identical to the ones used in validated 
test batteries, such as the short physical performance battery (Guralnik et al., 1994). During these 
 45 
 
tests, the position of the center of pressure (COP) on the platform is recorded. In addition to the 
traditional scoring of these balance tests, outcome parameters (e.g., total COP path length [m], 
sway area [m2], mean velocity [m/s]) can be measured. These parameters can be used to describe 
the direction and extent of postural sway. The smaller the COP path length or sway area, the 
better the stability. The velocity (i.e., COP path length divided by trial duration) represents the 
amount of activity required to maintain stability; the smaller the COP velocity, the better the 
postural control (Treffel et al., 2016). 
Safety of Muscle Mechanography 
 
Muscle mechanography has been used in many research studies across various 
populations, including young and older adults (Buehring et al., 2015; Dietzel, Felsenberg, & 
Armbrecht, 2015; Hardcastle et al., 2014; Matheson et al., 2013; Rittweger et al., 2004; Runge et 
al., 2004; Siglinsky et al., 2015; Singh et al., 2014), athletes (including master athletes) (Ireland 
et al., 2015; Michaelis et al., 2008), as well as children and adolescents (Binkley & Specker, 
2008; Fricke, Weidler, Tutlewski, & Schoenau, 2006; Veilleux & Rauch, 2010). None of these 
studies reported pain, falls, or fractures while using muscle mechanography. Furthermore, in the 
current authors' unpublished data of more than 300 older adults, all participants were able to 
complete most tests on the platform (<5% were not able to perform countermovement jumps). 
Mild joint pain was the only complaint, but there were no lasting adverse events. 
Buehring et al. (2015) conducted a study to examine the safety of jumping 
mechanography (using countermovement jumps) in an older population including individuals 
with osteoporosis and prior vertebral fracture. Jumping mechanography was determined to be a 
safe and useful method. Self-reported pain did not change after countermovement jumps and no 
injuries or new vertebral fractures were sustained, even in individuals with low bone mass 
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density and previous vertebral fractures (Buehring et al., 2015). Individuals older than 90 with 
moderate control of balance, who were unable to perform the repeated chair-rise test, were able 
to complete other tests, including countermovement jumps, without any complaints or adverse 
events (Rittweger et al., 2004). Very frail individuals may ask for more assistance to complete 
countermovement jumps and some may only be able to perform heel rises. Evidence supports the 
safety of muscle mechanography in older adults. 
Reproducibility of Muscle Mechanography 
 
The reproducibility of muscle mechanography has been examined in several studies 
(Fricke et al., 2006; Matheson et al., 2013; Rittweger et al., 2004; Veilleux & Rauch, 2010). 
Buehring et al. (2015) have recently found that jumping mechanography (i.e., using 
countermovement jumps) has excellent test–retest reliability compared to other traditional 
muscle function tests in 97 adults age 70 and older. Jumping mechanography and grip strength 
had the highest intraclass correlation coefficients (ICC) (0.93 and 0.95, respectively), whereas 
traditional chair rises and gait speeds had lower ICCs (0.81 and 0.76, respectively). 
Other literature supports the finding that jumping mechanography and gait speed perform 
better than Timed Up and Go, 10-m gait speed, and chair-rise tests (Rittweger et al., 2004). 
Jumping mechanography has good test–retest reliability, with low intra-subject, short-term error 
(3.6%); large inter-subject coefficient of variation (45.4%); and a high test–retest correlation 
coefficient (r = 0.99) (Rittweger et al., 2004). Good reproducibility results of muscle 
mechanography are further supported in samples of children and middle-aged adults (Matheson 
et al., 2013; Veilleux & Rauch, 2010). Interrater coefficients of variation were <0.6% for the 
two-leg countermovement jumps and intrarater coefficients of variation were <5.3% for all 
variables (Matheson et al., 2013). Veilleux and Rauch (2010) reported coefficients of variation 
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ranged from 3.4% to 7.5% for multiple one- and two-legged jumps, single two-legged jumps, 
and heel-rise tests. 
Muscle mechanography is a method that has well-documented reliability, reproducibility, 
and promises to be a sensitive test to detect even small functional changes in older adults. In 
addition, it has less test variability than other traditional muscle function tests (e.g., gait speed, 
chair rise). 
Implementing Muscle Mechanography in Nursing Research 
 
Most nursing research studies involve the collection of data through traditional methods, 
such as self-reporting or observation tools. Using innovative and advanced methodology in 
nursing research is highly recommended (NINR, 2011). A growing body of evidence indicates 
that identifying muscle power, with specific attention to the contribution of force and velocity, is 
a critical component in the design of intervention strategies aimed at ameliorating muscle 
function and physical ability in older adults (Pojednic et al., 2012). Muscle mechanography 
provides in-depth knowledge of the individual contributions of force and velocity to muscle 
power so interventions can be tailored to optimize the most influential component. Muscle 
mechanography can also be used to evaluate the potential of nursing therapeutic interventions in 
older adults (Caserotti et al., 2001; Dietzel et al., 2015; Rantalainen et al., 2010; Runge et al., 
2004; Singh et al., 2014; Tsubaki et al., 2016). 
The current review highlights potential advantages of muscle mechanography, including 
(a) that it is computerized (making it less prone to human error and variation), (b) being able to 
report actual physical units of interest for particular tests, (c) assessing a wide range of physical 
ability (less ceiling or floor effects), and (d) that it is reproducible and safe in older adults. 
Muscle mechanography can assist nursing researchers toward building a comprehensive picture 
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of the muscle function in older adults, predicting the onset of physical decline, and identifying 
the changes in muscle function parameters potentially more precisely than traditional methods 
(Buehring et al., 2015; Fricke et al., 2006; Matheson et al., 2013; Pojednic et al., 2012; Rittweger 
et al., 2004; Veilleux & Rauch, 2010). Because of these advantages, muscle mechanography has 
the potential to reduce the sample size, duration, and total cost of research studies. 
Despite all these advantages, muscle mechanography has some limitations. First, 
although the method can be performed by most older adults, some may be unable to perform 
some tests due to severe frailty or significant physical impairments. However, even very frail 
older adults can perform at least one or two of the available tests. Second, studies are lacking to 
determine whether muscle mechanography results can be used to predict outcomes such as 
fractures, hospitalizations, and mortality. As researchers become familiar with muscle 
mechanography and begin incorporating this technology into more studies, data will be available 
to fill gaps in evidence. Muscle mechanography correlates well with measures of maximal force, 
such as grip strength and muscle mass, and also traditional muscle tests (Siglinsky et al., 2015). 
Many studies show that these muscle function parameters are associated with health outcomes 
among older adults. For example, muscle force correlates with bone health in older adults 
(Hardcastle et al., 2014; Rantalainen et al., 2009), and muscle power correlates with age 
(Buehring et al., 2010; Rantalainen et al., 2010; Runge et al., 2004), fall risk (Caserotti et al., 
2001; Runge & Hunter, 2006; Runge et al., 2004), impaired physical performance and activities 
of daily living (Caserotti et al., 2001; Dietzel et al., 2015; Runge et al., 2004; Tsubaki et al., 
2016), and sarcopenia (Siglinsky et al., 2015; Singh et al., 2014). As such, although no direct 
evidence exists that muscle mechanography can predict health outcomes, the correlation of 
muscle mechanography with traditional muscle function tests suggests that it could. Jumping 
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mechanography has already been integrated into prospective studies and outcome results should 
be available in the next few years. 
Conclusion 
 
Muscle mechanography is an innovative and safe research tool for measuring muscle 
function in older adults that offers several advantages to currently used methods. Muscle 
mechanography is consistent with the movement toward an increased use of highly innovative 
technology to quantitatively measure health status and outcomes. More research is needed to 
examine whether muscle mechanography can predict health outcomes such as falls, fractures, 
loss of independence, hospitalizations, and mortality. 
Chapter Summary 
 
The first manuscript in this chapter introduced the phenomenon of sarcopenia in older 
adults. Gaps in knowledge were discussed and recommendations for future studies were 
addressed. The second manuscript in this chapter introduced muscle mechanography (MM) as a 
novel method that can be used to quantitatively assess muscle function parameters in older 
adults. The manuscript covered the mechanism of MM, the different types of tests, the 
parameters that can be obtained by using MM, and the measurement procedures. The safety and 
reproducibility of MM were also discussed. 
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CHAPTER 3 
 
Chapter Introduction 
 
The purpose of this study is threefold: 1) to describe the characteristics of muscle mass, 
strength, and function in older adults living in RCACs, 2) to determine, after controlling for pain, 
whether there is a difference in muscle mass, strength, and function among RCACs residents 
based on self-efficacy for exercise, depression, and social support levels, and 3) examine the 
convergent validity of MM with widely used traditional muscle function tests (i.e., SPPB, TUG, 
and grip strength). The overall goal of this study is to improve sarcopenia prevention research 
and practices, as well as to improve the physical function and delay LTC placement among 
RCACs residents. 
Method 
 
Research Design 
 
This study is a secondary data analysis using a cross-sectional descriptive correlational 
design. The descriptive correlational design is intended to describe the association between the 
dependent and independent variables and provide information to generate future hypotheses and 
research. Data for this study were collected for a randomized, crossover design study that 
explored the effect of semi-recumbent vibration exercise on muscle mass, strength, and function 
in older adults. This study only included data collected at baseline prior to the intervention and 
control condition participation. Secondary data analysis is feasible as the data collection is 
usually time consuming and expensive. Secondary data analysis is also an effective way for new 
researchers with limited resources to begin to answer important research questions (Polit, & 
Beck, 2012). It is important to acknowledge that the available data set provides a unique access 
to vulnerable and understudied population. 
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The author of this study was the primary coordinator for the primary study. He was 
responsible for all aspects of study conduct such as recruiting, scheduling exercise sessions, 
supervising the interventions, and coordinating the assessment visits.  
Research Questions and Hypotheses 
 
The research questions that were addressed in this study include: 
1) What are the self-efficacy for exercise, depression, and social support of older adults 
living in RCACs? 
2) What are the muscle mass, strength, and function of older adults living in RCACs? 
The hypotheses for this study include: 
1) Participants with high self-efficacy for exercise will have greater muscle mass, strength, 
and function than those with low self-efficacy for exercise. 
2) Participants without depressive symptoms will have greater muscle mass, strength, and 
function than those with depressive symptoms. 
3) Participants with high social support will have greater muscle mass, strength, and 
function than those with low social support 
4) Weight corrected jump power obtained by MM correlates well with other traditional 
muscle function and strength tests, including SPPB, TUG, and grip strength. 
Sample and Setting  
 
The participants of the original study were recruited from one RCAC located in a 
Midwestern city that was chosen by convenience. Inclusion criteria for research participants in 
the primary study included English-speaking older adults age 70 and older with no significant 
cognitive impairment. Participants were able to stand without assistance and free of any major 
illness such as end-stage organ disease. Excluded were older adults who could not speak English, 
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had any injury or surgery in the last six months that limits ability to move around, or were not 
able to stand without assistance. The participants of the original study were recruited through 
flyers and community talks in the facility. The study coordinator explained the study to potential 
participants and answered their questions and concerns.  
A total of 63 residents were solicited for participation in the primary study. Only 31 
residents participated in the primary study. The entire sample of 31 participants were included in 
this secondary analysis. Many residents decided not to participate in the primary study. The most 
common reason residents declined to participate is that their schedule was already very busy and 
could not accommodate the exercise sessions. Other reasons include being not interested, having 
a deteriorated health status and frequent doctors' appointments, and providing care for an ill 
spouse. This study is underpowered, which will be discussed more thoroughly under Data 
Analysis Plan and Limitation Sections. 
Instruments 
 
This section of the paper provides a description of the tools that were used in the original 
study to measure the dependent and independent variables. The baseline measures of these 
variables before any intervention was started were use in this secondary analysis. 
Dependent variables. The dependent variables measured in the primary study are muscle 
mass, muscle strength, and muscle function. 
Muscle mass. A bioimpedance spectroscopy (ImpediMed SFB7) device was used to 
measure body composition including skeletal muscle mass. The device scans 256 frequencies 
between 4 kHz and 1000 kHz. The device utilizes Cole modelling with Hanai mixture theory to 
determine total body water (TBW), extracellular fluid (ECF) and intracellular fluid (ICF) from 
impedance data. Fat-free mass (FFM) and fat mass (FM) are then calculated on the device 
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(Yamada et al., 2013). Skeletal muscle mass (SM) was calculated using the equation developed 
by Janssen and colleagues where SM (kg) = [(height2 /R50 × 0.401) + (sex × 3.825) + (age × –
0.071)] + 5.102. Height was measured in centimeters, R50 was measured in ohms between the 
right wrist and ankle in a supine position (men = 1 and women = 0), and age was measured in 
years (Janssen, Heymsfield, Baumgartner, & Ross, 2000).  
Compared to the existing methods for assessing body composition (e.g., magnetic 
resonance imaging (MRI), computed tomography (CT), and dual-energy X-ray absorptiometry 
[DXA]), BIS is an affordable, noninvasive, easy-to-operate, and portable method for assessing 
lean mass in older adults (Yamada et al., 2013). BIS was found to be valid and reliable method to 
assess body compositions in young and older adults (Janssen et al., 2000; Sun et al., 2005; 
Yamada et al., 2013).  Janssen and colleagues reported correlation coefficients between skeletal 
muscle mass determined by BIS and skeletal muscle mass measured by MRI exceeding 0.88 and 
standard errors of the estimate of 9% in a multiethnic sample of 158 women and 230 men 
(Janssen et al., 2000). In another study, body fat estimates by BIA (18.6 +/- 9.2 kg) was not 
significantly different from those obtained by DXA (18.2 +/- 7.9 kg). DXA showed a relatively 
good agreement with BIA [-0.39 +/- 3.3 (-6.9 to 6.1) kg] in all patients (Sun et al., 2005). 
Muscle strength. Muscle strength is related to hand grip strength. The purpose of grip 
strength test is to measure the maximum isometric strength of the hand and forearm muscles. 
Grip strength was measured using a JAMAR® hand dynamometer, which is the “gold standard” 
for the measurement of grip strength (Mathiowetz, 2002). Each participant performed the test 
three times using participant’s non-dominant hand and the greatest score was selected for 
analysis.  
Grip strength test has been widely used among older adults. Low grip strength is 
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predictive of limited physical function, disability, longer hospitals stays, and mortality 
(Bohannon, 2015). Grip strength is inversely associated with all-cause mortality, cardiovascular 
mortality, non-cardiovascular mortality, myocardial infarction, stroke, fall, and fracture (Leong 
et al., 2015). Grip strength has an excellent inter-instrument reliability, intraclass correlation 
coefficients ranged from 0.90 to 0.97 (Mathiowetz, 2002). Another study examined the test–
retest reliability of grip strength measured using a JAMAR® hand dynamometer over a 12-week 
period in older adults (Bohannon & Schaubert, 2005). Test and retest measurements did not 
differ significantly over time on either side. Intraclass correlation coefficients were 0.95 and 0.91 
for the left and right hands, respectively (Bohannon & Schaubert, 2005). 
Muscle function. Muscle function was measured by three tools: SPPB, MM, and TUG. 
SPPB. The SPPB test is a feasible, useful, and commonly used tool to assess muscle 
function in older adults. SPPB test focuses primarily on lower extremity function and includes 
three components: a) a 4 meter walk at a usual pace to measure gait speed, b) one chair rise 
followed by 5 timed chair rises if the first is successfully completed, and c) balance stands with 
the feel held in different positions for 10 seconds each (Appendix B). The total score is range 
from 0 (worst performance) to 12 (best performance). Based on their SPPB scores, individuals 
can be classified with mobility limitations (0-9), or without mobility limitations (10-12) 
(Bernabeu-Mora et a., 2015; Guralnik, Ferrucci, Simonsick, Salive, & Wallace, 1995).  
The SPPB test has been widely used among older adults and is predictive of nursing 
home admission and mortality (Guralnik et al., 1994). A study showed that the test has a test-
retest reliability of 0.87 (CI 95%: 0.77-0.96) in older adults aged 65 to 74 years (Gómez, Curcio, 
Alvarado, Zunzunegui, & Guralnik, 2013). Another study demonstrated evidence of validity and 
reliability of the SPPB in two very different populations (Freire, Guerra, Alvarado, Guralnik, & 
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Zunzunegui, 2012). The validity of the SPPB was demonstrated by the strong and consistent 
association with health status measures, in spite of the socioeconomic and cultural differences 
between the both groups. There was a graded decrease in mean SPPB scores with increasing 
limitation of lower limbs, disability, and poor health. Using the test–retest reliability the authors 
evaluated the intraclass correlation coefficient, which was high in both groups: 0.89 (95% CI: 
0.83, 0.93) in the first group and 0.83 (95% CI: 0.73, 0.89) in the second group (Freire et al., 
2012). 
MM. MM is a tool that provides an objective quantification of the muscle function 
parameters of the lower limbs, including muscle power and force (Taani et al., 2017). Several 
tests can be performed through MM including the two-leg maximal countermovement jump. The 
countermovement jump was used to assess weight corrected jump power among the participants. 
This test has good test-retest reliability with low intrasubject short-term error (3.6%), large 
intersubject coefficient of variation (45.4%), and a high test-retest correlation coefficient (r=.99) 
(Rittweger, et al., 2004). 
In a study by Buehring and colleagues, the countermovement jump test had excellent 
test–retest reliability compared to other traditional muscle function tests among older adults. The 
test had the highest intraclass correlation coefficients (ICC) (0.93), whereas traditional chair rises 
and gait speeds had lower ICCs (0.81 and 0.76, respectively) (Buehring et al., 2015). Detailed 
description of MM is provided in chapter 2 of this dissertation.  
TUG. The TUG test includes the measurement of the time in seconds for an individual to 
rise from sitting from an armless chair, walk 3 meters, turn, walk back to the chair, and sit down 
(Appendix C). The test is a commonly used measure of functional mobility due to its 
requirement of performing multiple tasks such as standing up, walking, turning around 180 
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degrees, and sitting down (Podsiadlo & Richardson, 1991). The test is quick and easy to 
administer and requires no special equipment.  
Although formal normal values are not available, a study found that older adults who 
completed the TUG test in less than 20 seconds were independent for basic transfers (e.g., tub 
and shower transfers) and ability of going outside alone while older adults who completed the 
test in more than 30 seconds tend to be much more dependent (e.g., need help with chair and 
toilet transfers, get in and out of the tub or shower) and were not able to go out alone (Podsiadlo 
& Richardson, 1991). The TUG test correlates with balance, gait speed, and functional capacity. 
The test also has a test-retest reliability of 0.99 (Podsiadlo & Richardson, 1991).   
Independent variables. The independent variables measured in the primary study are 
self-efficacy for exercise, depression, social support, and pain.  
Self-efficacy for exercise. Self-efficacy for exercise scale (SEE) was used to assess 
perceived self-efficacy and confidence to participate in exercise (Appendix D). The SEE scale 
was particularly designed for older adults and developed from a continuing care retirement 
community population (average age 85). The SEE scale is an 9-item scale with a possible range 
of scores of 0 to 90. For each item, the individual uses the scale from 0 (Not Confident) to 10 
(Very Confident) to describe his/her current confidence that he/she could exercise 3 times a week 
for 20 minutes each time (Resnick & Jenkins, 2000). Total score is calculated by summing the 
responses to each question. A higher score indicates higher self-efficacy for exercise.  
Prior use of the SEE scale in older adults living in a continuing care retirement 
community provided evidence of reliability and validity (Resnick & Jenkins, 2000). The scale 
demonstrated internal consistency with an alpha coefficient of 0.92 and validity by finding a 
significant correlation between scores on the SEE and exercise behavior (r = 0.56, P < .05) 
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(Resnick & Jenkins, 2000). 
Depression. Depression was measured using the short form of the Geriatric Depression 
Scale (GDS) (Appendix E). Although there are many tools available to assess for depression, the 
GDS was designed specifically for older adults and its items were developed after careful 
consideration of unique characteristics of depression in older adults (Sheikh & Yesavage, 1986). 
The scale assesses the symptoms of diminishing interest in activities, diminishing in social 
activities, life satisfaction, feeling of worthlessness, cognitive impairment, and suicidality 
(Sheikh & Yesavage, 1986). The short form of the GDS is more easily used by physically ill and 
mildly to moderately demented patients who have short attention spans and/or feel easily 
fatigued. The short form of the GDS is a self-report scale consists of 15 yes/no questions. Each 
question is scored as either 0 or 1 points depending upon whether the item is worded positively 
or negatively (Sheikh & Yesavage, 1986). Of the 15 items, 10 items indicate the presence of 
depression when answered positively, while the rest of the items (1,5,7,11,13) indicate 
depression when answered negatively. A score > 5 points is suggestive of depression and a score 
≥ 10 points is almost always indicative of depression. The GDS was found to have Crohnbach’s 
alpha of 0.94, and a 92% sensitivity and an 89% specificity when evaluated against diagnostic 
criteria (Allen & Annells, 2009; Marc, Raue, & Bruce, 2008). 
Social support. Social support was measured by the abbreviated version of the Lubben 
Social Network Scale (LSNS-6) (Appendix F). The LSNS-6 is a six-item, self-reported scale to 
assess social isolation in older adults aged 65 years and older by measuring perceived social 
support received by family and friends (Lubben et al., 2006). The LSNS-6 assesses the size, 
closeness, and frequency of contacts of a respondent’s social network including both kin/family 
and nonrelated individuals. The LSNS-6 consists of two subscales: Family subscale which 
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consists of three times that ask about relatives and Friends subscale which consists of three times 
that ask about friends. The total scale score is the sum of the six items and ranges from 0 to 30, 
where high scores indicate good informal social support. Individuals scoring < 12 indicate a 
positive screen for social isolation and should be considered candidates for additional assessment 
and referral (Lubben et al., 2006). Participants screening positive on the LSNS-6 are considered 
socially isolated. Scores of less than 6 on the three-item LSNS-6 Family subscale are considered 
to have marginal family ties and those with scores of less than 6 on the three-item LSNS-6 
Friends subscale to have marginal friendship ties. 
Low scores have been correlated with physical health problems (Mor-Borak, Miller, & 
Syme 1991), all-cause hospitalization (Mistry, Rosansky, McQuire, McDermott, & Jarvik, 
2001), depression (Dorfman et al., 1995), lack of adherence to good health practices (Potts, 
Hurwicz, Goldstein, & Berkanovic, 1992), and mortality (Ceria et al., 2001). LSNS-6 is a 
reliable and valid tool for the measurement of social support. Crohnbach’s alpha for the 
subscales ranges from 0.80 to 0.89 (Lubben et al., 2006). 
Pain. Pain was assessed by the Numeric Rating Scale (NRS), which is a useful tool to 
assess pain in individuals who can point to or state the number that reflects their current pain 
level (Appendix G). The NRS is a widely-used scale to assess pain among cognitively intact 
young and older adults (Herr, Spratt, Mobily, & Richardson, 2004). The NRS is an 11-point 
scale from 0 to 10 (0 = no pain, 1-3 = mild pain, 4-6 = moderate pain, 7-10 = sever pain). 
Individuals verbally select a value that is most in line with the intensity of pain that they have 
experienced in the last 24 hours. 
The NRS has adequate test-retest reliability for a single pair of assessments (one 
assessment during week 1, one assessment during week 2) (r = 0.63) and good test-retest 
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reliability for ratings on 2 or more days during week 1 compared to 2 or more days during week 
2 (r = 0.79 – 0.92) (Jensen & McFarland, 1993). The scale also has excellent interrater reliability 
with 100% agreement between two raters and good internal consistency in participants aged 65 
to 94 years (Cronbach’s alpha = 0.87) (Herr et al, 2004). The NPR has good sensitivity while 
producing data that can be statistically analyzed (Williamson & Hoggar, 2005) 
Other variables. Additional variables were measured to describe the sample, including 
age, sex, and body mass index (BMI). Weight (in kilograms) and height (in centimeters) were 
measured. BMI was calculated by using the formula, weight in kilograms divided by the square 
of the height in meters. To assess the number of falls in the last year and the number of fractures 
after age 50, the following questions were used: “How many times have you fallen in the last 
year?” and “Have you ever broken a bone over age 50? If yes, how many times?” 
Research Procedures 
 
This section describes the data collection procedures conducted in the primary study. All 
potential subjects were scheduled for a screening visit to collect information about eligibility. An 
appointment was made to do the assessment session at the facility. Three subjects did not meet 
the eligible criteria. One subject had a recent hip surgery, one subject had a back surgery, and 
one subject had a severe end organ disease. All the collected information from these three 
subjects who did not meet the inclusion criteria to participate was destroyed. Participants were 
provided with a reminder call within 24 hours of the scheduled data collection session. In the 
data collection session, the study questionnaires (SEE, GDS, LSNS, and NRS) were 
administered and MM, BIS, SPPB, TUG, and grip strength tests were performed. The purpose of 
each tool was explained to the participant.  
Two strategies were used to reduce participant burden and potentially limit missing data: 
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1) the data collectors administered the tools by interview; and 2) the participants were asked if 
they are fatigued and want to finish the questionnaires or muscle function tests after a break. In 
addition, participants were familiarized and instructed on the correct method to perform the 
muscle function tests. All tests were demonstrated by the data collectors before the participants 
performed any of the tests. Two data collectors were presented during performance of all muscle 
function tests and all participants wore a gait belt to enhance safety. Testing was done in a 
private and quiet location at the facility. The research team met regularly to assure that all 
recruitment, consent, and data collection and measurement procedures were met. 
Data Analysis Plan 
After gaining access to the de-identified data, all data were entered into a password 
protected database. Cases with missing data were included in the analysis where they had 
complete data. Statistical analysis was performed using Statistical Package for Social Sciences 
software (version 21, SPSS, Inc, Chicago, IL, USA). The study is underpowered due to the small 
sample size. Therefore, descriptive analysis is reported. The descriptive results provide new 
information about a vulnerable and difficult to access population. The findings provided 
information regarding effect sizes between the independent and dependent variables. Inferential 
analyses were performed with acknowledgement of the potential for Type II error. The data 
analysis plan is documented in Appendix I. 
Descriptive statistics of frequencies, means, standard deviations and ranges were used to 
describe the sample and answer questions 1 and 2 (Appendix I). Assumptions for statistical tests 
were examined. The distributions of all continuous variables were examined for skewness and 
the skewness calculations showed no skewness. The correlation coefficient values between pain 
and the dependent variables (i.e., muscle mass, strength, and function) indicated that pain was 
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not a significant factor. After eliminating the covariate (pain), multiple t-tests were carried out to 
answer the first three hypotheses (1, 2, and 3). T-test was used to determine the association 
between the independent variables (i.e., self-efficacy for exercise, depression, and social support) 
and dependent variables (i.e., muscle mass, strength, and function). Pearson's product moment 
correlation coefficient values between traditional muscle function tests (i.e., gait speed, grip 
strength, chair rise, SPPB, and TUG) and muscle power were reported to describe the convergent 
validity of MM with other traditional muscle function tests (Hypothesis 4). 
Strengths and Limitations 
This study has several strengths. First, the results of this study contributed to the body of 
knowledge on sarcopenia and its cognitive and psychosocial risk factors among vulnerable and 
understudied population. Second, using sophisticated equipment to measure the outcome 
variables provided precise measurements of muscle mass, strength, and function. Third, the study 
allowed to examine the convergent validity of MM with widely used traditional muscle function 
tests. However, this study has several limitations. A descriptive, correlational design is limited in 
the results that can be reported and causality cannot be inferred. Only strength of relationships 
between variables was reported. The small sample size was another limitation, which limits 
generalizability. This is due to the fact that this analysis was secondary in nature and the sample 
size was predetermined. However, the results were used to gain more information on effect sizes 
between the independent and dependent variables. The small sample size and inferential analyses 
planned may lead to a Type II error. Moreover, the original study recruited participants from one 
facility as well as individuals with end-stage organ disease, cognitive impairment, recent injury 
or surgery that limits ability to move around, and who were unable to stand without assistance 
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were excluded. These limitations produce a homogenous sample and limit generalizability to a 
broader population. Thus, findings will need to be viewed with caution.  
Measurement error can be a significant threat to the internal validity of this study. The 
SPPB and TUG tests have limitations including that older adults who have very low functional 
ability may not be able to perform these tests. Other limitations of these tests include 
dichotomous (yes/no) determinations and being prone to human errors as the final results depend 
on the times taken by individual examiners. Although BIA is inexpensive, noninvasive, and well 
correlate with MRI and DXA predictions, the use of BIA to assess muscle mass presents a 
drawback because the dehydration problem that can be observed in older adults. Dehydration 
causes an increase in the body's electrical resistance, which may result in an underestimation of 
fat-free mass and an overestimation of body fat. A significant limitation in this study was that all 
the potential confounding variables could not be controlled for, which may affect the results. 
Finally, although self-efficacy, depression, and social support were measured using validated 
scoring systems, the scores may not be robust due to only one time measurement. Future 
longitudinal studies, including large-scale cohort studies, and repeated measures are necessary 
and would improve accuracy by providing more robust findings. 
Chapter Summary 
 
The goal of this cross-sectional descriptive correlation study was to fill the gaps that 
currently exist in the literature about the relationship between self-efficacy for exercise, 
depression, and social support and sarcopenia in older adults. The study also examined the 
convergent validity of MM with widely used traditional muscle function tests (i.e., SPPB, TUG, 
and grip strength). This chapter provided an overview of the sample, procedures used in the 
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primary study for data collection, and the instruments and data analysis methods used in this 
study. Finally, this chapter discussed the limitations of this study. 
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CHAPTER 4 
 
Chapter Introduction 
 
In this chapter the study design, setting, and sample are described. The measurement 
methods and statistical analysis procedures used are described, and the study results are 
discussed. Characteristics of self-efficacy for exercise, depression, social support, muscle 
outcomes including muscle mass, strength, and function are reported and discussed. The findings 
on the associations between these variables, as well as the convergent validity of MM are 
discussed. Finally, limitations and potential implication of the study findings are addressed. 
Introduction 
 
Sarcopenia is a geriatric syndrome characterized by a reduction in muscle mass, strength, 
and function in older adults (Cruz-Jentoft et al., 2010). This reduction leads to negative outcomes 
including reduced mobility and independence, falls, and fractures (Bruyère et al., 2016). 
Sarcopenia also increases usage of long-term care facilities and nursing homes, hospitalization, 
morbidity, and mortality, which places a burden on individual, family, and healthcare system 
(Bruyère et al., 2016; Clark & Manini, 2010; Hirani et al., 2015; Janssen, 2010). Estimates 
indicate that sarcopenia costs the U.S. healthcare system around $18.5 billion annually (Janssen, 
et al., 2004). 
The etiology of sarcopenia is multifactorial, consisting of hormonal changes, endocrine 
issues, protein synthesis, proteolysis, inflammatory processes, physical inactivity and 
malnutrition (Fielding et al., 2011; Henwood et al., 2014). While these mechanisms and their 
role on the onset and progression of sarcopenia are well understood, other factors including 
cognitive and psychosocial factors are poorly understood. For example, physical activity and 
exercise have shown promises in preventing sarcopenia and improving physical function (Cruz-
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Jentoft et al., 2014; Kamel, 2003; Morley, 2012). People who are physically inactive or lead a 
sedentary lifestyle are less likely to stimulate the muscle regeneration process, making them 
more susceptible to developing sarcopenia (Gianoudis et al., 2014; Morley, 2012). Only 51.1% 
and 21.9% of older adults meet the recommended aerobic and resistance-training guidelines, 
respectively (Brady & Straight, 2014). It is crucial to explore which factors might underlie any 
effects of physical activity and exercise on physical function and muscle outcomes. Self-efficacy 
is a major predictor of physical activity and exercise among older adults as it can enhance or 
impede the motivation to exercise and be active (Goisser et al., 2015; McAuley et al., 2011). 
However, the influence of self-efficacy is one of the major aspect that is rarely addressed so far 
in sarcopenia research (Brady et al., 2014; Goisser et al., 2015), and yet no studies have been 
conducted to addressed the association between self-efficacy and sarcopenia.  
Sarcopenia and depression seem to share several common risk factors, such as physical 
inactivity, malnutrition, hormonal dysregulation, and upregulation of inflammatory markers such 
as cytokines (Bauer et al., 2013; Beaudart et al., 2014; Cruz-Jenoft et al., 2010; Fiske et al., 
2009; Morley et al., 2010; Muir & Montero-Odasso, 2011). However, recent studies showed 
inconsistent results about the association between sarcopenia and depression. Hsu and colleagues 
found that sarcopenia was associated with depressive symptoms (Hsu et al., 2014), whereas 
Byeon and colleagues reported no association between depression and sarcopenia among older 
adults (Byeon et al., 2016). Social support and sarcopenia also appear to share common risk 
factors. Social support impacts the relationship between self-efficacy and self-management 
behaviors and predicts the physical health in older adults (Gallant, 2003). While older adults who 
have strong social support are less likely to lead inactive lifestyles and be depressed, individuals 
with poor social support are prone to be isolated, depressed, and inactive (Wallace et al., 2015; 
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Yeom et al., 2008). These outcomes negatively impact the physical function in older adults. 
More research is needed to further examine the association between social support and 
sarcopenia. A greater understanding of the factors contributing to sarcopenia is crucial to prevent 
sarcopenia and design intervention to decrease its potential consequences.  
In addition, it is suggested that the lack of appropriate assessment and treatment is a 
critical factor for increased physical impairments (Giuliani et al., 2008; Roberts et al., 2013). 
Many traditional methodologies exist to assess muscle function; however, all have important 
limitations. These limitations include yes/no determinations (e.g., balance test) and floor effect 
(e.g., chair rise test has). The traditional tests are also prone to tester subjectivity as the results 
depend on the time taken by individual examiners (e.g. SPPB, gait speed, TUG) (Buehring et al., 
2010; Taani et al., 2017). Thus, performing more sophisticated assessment of muscle function is 
needed to identify limitations, understand the predictive value of specific impairments, and target 
intervention modalities (Giuliani et al., 2008; Guralnik et al., 1994; Taani et al., 2017).  
Muscle Mechanography (MM) is a promising tool for assessing muscle function and 
obtaining benchmarks for functional data (Taani et al., 2017). MM provides an objective 
quantification of muscle function parameters including muscle power and force by using 
maximal countermovement jumps, serial hopping, or heel raises performed on a ground reaction 
force platform. However, data comparing MM with traditional muscle function tests is limited 
and further research is needed to validate MM with other commonly used muscle function tests 
(Buehring et al., 2015; Rittweger et al., 2004; Siglinsky et al., 2015). 
This study aimed to describe the self-efficacy for exercise, depression, and social support 
of the participants as well as their muscle characteristics including muscle mass, strength, and 
function. In addition, four hypotheses were tested:  
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1) Participants with high self-efficacy for exercise will have greater muscle mass, strength, 
and function than those with low self-efficacy for exercise. 
2) Participants without depressive symptoms will have greater muscle mass, strength, and 
function than those with depressive symptoms. 
3) Participants with high social support will have greater muscle mass, strength, and 
function than those with low social support. 
4) Weight corrected jump power obtained by MM correlates well with other traditional 
muscle function and strength tests, including SPPB, TUG, and grip strength. 
Methods 
 
Study Design  
 
This is a secondary data analysis using data collected for a randomized crossover design 
study to investigate the effectiveness of semi-recumbent vibration exercise on muscle mass, 
strength, and function in older adults. The study consisted of several visits; screening and 
baseline visit followed by eight weeks of training three times a week, visit at eight weeks 
followed by four weeks of washout, visit at 12 weeks followed by eight weeks of training three 
times a week, and a final visit at 20 weeks. Each participant signed an IRB-approved, protocol-
specific informed consent in accordance with the IRB of University of Wisconsin Madison.  
At the screening visit, participants were asked information about their medical history 
including fractures and falls within the last 12 months. At the baseline visit several 
questionnaires were obtained and participants then were proceeded with muscle function tests 
(SPPB, grip strength, TUG, and MM). Participants were then randomized into one of two 
groups, the first group received vibration treatment for the first eight weeks and the second group 
received sham treatment. After eight weeks both groups have gone through a 4-week wash-out 
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period and then crossover occurred. The participants were trained for 10 minutes, three times a 
week, during the active 16 total weeks.  
Study Sample  
 
In the primary study, 31 older adults were recruited from a Residential Care Apartment 
Complex (RACA) located in the Midwestern United States. Study eligibility requirements 
included English-speaking older adults age 70 and older with no significant cognitive 
impairment. Participants were able to stand without assistance and free of any major illness such 
as end-stage organ disease. Excluded were older adults who could not speak English, those had 
any injury or surgery in the last six months that limits ability to move around, or those who were 
not able to stand without assistance. The entire sample of 31 participants were included in this 
secondary analysis and only baseline data collected from the participants were used. 
Measures 
 
Demographic data were obtained such as age, sex, and BMI. Weight (in kilograms) and 
height (in centimeters) were measured. The formula used to calculate BMI is weight (Kg)/height 
(cm2) (Jensen et al., 2013). To assess the number of falls and the number of fractures after age 
50, the following questions were used: “How many times have you fallen in the last year?” and 
“Have you ever broken a bone over age 50? If yes, how many times?” 
Self-efficacy for exercise. The Self-Efficacy for Exercise Scale (SEE) was used to assess 
participants' confidence in their ability to continue exercising despite barriers to exercise 
(Resnick & Jenkins, 2000). The SEE scale is an 9-item scale with a possible range of scores of 0 
to 90. The score of each item ranges from 0 (“not confident”) to 10 (“very confident”), with 
lower values indicating lower self-efficacy. The reliability, validity, and internal consistency 
(Cronbach α = 0.92) of the scale have been established (Resnick & Jenkins, 2000).  
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Depression. The short form of the Geriatric Depression Scale (GDS-15) was used to 
measure the depressive symptoms (Sheikh & Yesavage, 1986). The GDS-15 includes 15 yes/no 
questions with one point for each depressive symptom. The total score ranges from 0 to 15, with 
15 being most depressed. A cut-off point of  > 5 points can be considered as indicating 
depression. The scale was found to have Crohnbach’s alpha of 0.94, and a 92% sensitivity and an 
89% specificity when evaluated against diagnostic criteria (Allen & Annells, 2009; Marc et al., 
2008). 
Social support. The abbreviated version of the Lubben Social Network Scale (LSNS-6) 
was used to measure perceived social support received by family and friends (Lubben et al., 
2006). The scale consists of 6 items and it has two subscales: family and friends. The total score 
ranges from 0 to 30, higher scores indicating greater social support. Individuals scoring ≤ 11 
indicate a positive screen for social isolation and should be considered candidates for additional 
assessment and referral (Lubben et al., 2006). Participants screening positive are considered 
socially isolated. Crohnbach’s alpha for the subscales ranges from 0.84 to 0.89 (Lubben et al., 
2006). 
Pain. The Numeric Rating Scale (NRS) was used to assess the pain level. The NRS is an 
11-point scale from 0 to 10 (0 = no pain, 1-3 = mild pain, 4-6 = moderate pain, 7-10 = sever 
pain). The scale is a useful tool to assess pain in those who can state the number that reflects 
their current pain level and widely-used among older adults (Herr et al., 2004). The NRS has 
good test-retest reliability for ratings on 2 or more days during week 1 compared to 2 or more 
days during week 2 (r = 0.79 – 0.92) (Jensen & McFarland, 1993). It has also excellent interrater 
reliability with 100% agreement between two raters and good internal consistency in participants 
aged 65 to 94 years (Cronbach’s alpha = 0.87) (Herr et al, 2004). 
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Skeletal muscle mass. A bioimpedance spectroscopy (ImpediMed SFB7) device was 
used to measure body composition. The details of BIS have previously been described (Kaysen 
et al., 2005; Gudivaka, Schoeller, Spiegel, & Kushner, 1994). Skeletal muscle mass (SM) was 
calculated using the equation developed by Janssen and colleagues where SM (kg) = [(height2 
/R50 × 0.401) + (sex × 3.825) + (age × –0.071)] + 5.102. Height was measured in centimeters, 
R50 was measured in ohms between the right wrist and ankle in a supine position, and age was 
measured in years (Janssen et al., 2000). Compared to the existing methods (e.g., MRI and 
DXA), BIS is a feasible, noninvasive, and portable tool for assessing body composition (Yamada 
et al., 2013).  
Muscle strength-hand grip. This was measured using a JAMAR® handgrip 
dynamometer, which is the “gold standard” for the measurement of grip strength (Mathiowetz, 
2002). Subjects used their dominant hand unless otherwise instructed. Three measurements were 
taken and the highest score was recorded.  
Muscle function. Muscle function was measured by three tools: SPPB, MM, and TUG. 
SPPB test includes measures of standing balance (timing of tandem, semitandem, and side-by-
side stands), gait speed (4-m walking speed), and ability and the time needed to rise from a chair 
five times (Guralnik et al., 1994). Each component has a possible score of 0–4 and the total 
SPPB scores ranges from 0–12. Individuals can be classified with low performance (0-6), 
intermediate performance (7-9), and high performance (10-12) (Guralnik et al., 2000). TUG test 
includes the measurement of the time in seconds for an individual to rise from sitting from an 
armless chair, walk three meters, turn and walk back to the chair, and sit down. The test has a 
test-retest reliability of 0.99 (Podsiadlo & Richardson, 1991).  
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MM provides an objective quantification of muscle function parameters of the lower 
limbs, including muscle power (i.e., weight corrected jump power). The details of MM have 
previously been described (Taani et al., 2017). Several tests can be performed by MM including 
the two-leg maximal countermovement jump. Three jumps were performed on a force plate 
(Leonardo, Novotec, Pforzheim, Germany) by each participant and the jump with the greatest 
peak power was recorded. This test has good test-retest reliability with low intrasubject short-
term error (3.6%), large intersubject coefficient of variation (45.4%), and a high test-retest 
correlation coefficient (r=.99) (Rittweger et al., 2004).  
Statistical Analysis 
 
SPSS® version 21 was used for data analysis. Assumptions for statistical tests were 
examined. None of the continuous variables were skewed. Descriptive statistics were used to 
describe the self-efficacy for exercise, depression, social support, and muscle outcomes including 
muscle mass, strength, and function. Pain was tested for possible inclusion as a covariate but was 
not significantly related to the dependent variables. T-tests for independent samples were 
conducted to determine whether there is a difference in muscle outcomes (i.e., muscle mass, 
strength, and function) based on self-efficacy for exercise, depression, and social support 
(Hypothesis 1,2, and 3). Self-efficacy for exercise, depression, and social support variables were 
grouped by sample mean for self-efficacy and established cut-off points for depression and social 
support. Pearson's product moment correlation coefficients were used to examine the association 
of muscle function tests (i.e., gait speed, grip strength, chair rise, SPPB, and TUG) with weight 
corrected jump power obtained by MM (Hypothesis 4). This study is underpowered as the 
sample size was predetermined. The study focused on descriptive analyses, which provided new 
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information on a vulnerable and difficult to access population. Inferential analyses were 
performed with acknowledgement of the potential for Type II error.  
Results 
 
Sample Characteristics  
 
Thirty-one participants were included in the analysis. Participants’ ages ranged from 75 
to 99 with a mean of 88 years (SD = 6). Participants were predominately female (n= 21, 71 %), 
which is consistent with this population. Participants BMI ranged from 18.86 to 41.99 with a 
mean of 27.7 kg/m2 (SD = 5.12). Forty-one percent (n=9) of the sample had an incidence of fall 
in the past year. Five subjects reported more than one fall in the past year (16.2%) and 8 subjects 
reported only one fall in the past year (25.8%). Twelve subjects reported a broken bone over age 
50 years (38.7%). Only one subject reported three broken bones after age 50 years (3.2%), 5 
subjects reported two broken bones after age 50 years (16.2%), and 6 subjects reported only one 
broken bone after age 50 years (19.4%). These results are displayed in Table 2. 
 
Table 2 
Demographic Characteristics of Sample (n = 31) 
Characteristic M SD Range 
Age in years  88 6 75-99 
Body mass index (kg/m2)  27.70 5.12 18.86-41.99 
Characteristic n %  
Gender  
Male 
Female  
 
9 
22 
 
29 
71 
 
Fall   
Yes 
No 
 
13 
18 
 
41.9 
58.1 
 
Number of falls  
1  
More than 1 
 
8 
5 
 
25.8 
16.2 
 
Broken bone  
Yes 
No 
 
 12 
19 
 
                38.7 
                61.3 
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Number of broken bone 
1  
2  
3  
 
6 
5 
1 
 
19.4 
16.2 
3.2 
 
Note: Fall: Incidence of fall in the past year, Number of falls: Number of falls in the past 
year, Broken bones: Broken bones after age 50, Number of broken: Number of broken bone 
after age 50. 
 
Description of Self-efficacy, Depression, and Social Support 
 
The SEE was used to measure self-efficacy for exercise. The SEE scores ranged from 3 
to 89 with a mean of 50 (SD = 26.04). The GDS was used to screen for depression. Based on the 
established cut-off points, subjects who scored greater than 5 were classified as depressed and 
those who scored less than or equal 5 were classified as not depressed. The GDS scores ranged 
from 0 to 13 with a mean of 2.97 (SD = 2.79). Only four (12.9%) individuals were depressed. 
The LSNS results were categorized based on the established cut-off points as socially isolated (≤ 
11) and not socially isolated (> 11). The LSNS scores ranged from 2 to 25 with a mean of 14.71 
(SD = 6.98). Ten individuals were categorized as socially isolated (32.3%). These results are 
described in Table 3. 
 
Table 3 
Description of Self-efficacy, Depression, and Social Support (n = 31) 
Classification M SD Range n % 
SEE 50 26.04 3 to 89 31  
GDS 
Not depressed 
Depressed  
2.97 2.79 0 to 13  
27 
4 
 
87.1 
12.9 
LSNS 
Not socially isolated 
Socially isolated 
14.71 6.98 2 to 25  
21 
10 
 
67.7 
32.3 
Note: SEE: Self-Efficacy for Exercise Scale, GDS: Geriatric Depression Scale-15, LSNS: 
Lubben Social Network Scale-6. 
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Description of Muscle Mass and Strength 
 
Skeletal muscle mass (SM) was measured using BIS. The mean score of SM was 17.51 
kg (SD = 5.28). Muscle strength was measured by the grip strength (GS) test. The mean score of 
GS was 14 kg (SD = 5.91) (Table 4). There was a significant difference in the mean score of SM 
between men and women. The mean score of SM for men was 22.27 kg (SD = 6.9) and 15.56 kg 
for women (SD = 2.84); t(29) = 3.9, p = .001. There was also a significant difference in the mean 
score of GS between men (M = 21.78 kg, SD = 4.32) and women (M = 10.82 kg, SD = 2.50); 
t(29) = 8.901, p < .001. The results showed that men had greater SM and GS than women (Table 
5). 
 
Table 4 
Description of Muscle Mass and Strength (n = 31) 
Classification   M  SD 
SM 
 
 
  
 
 
17.51 5.28 
GS   14.00 5.91 
Note: SM: Total Skeletal Muscle Mass (kg), GS: Grip 
Strength (kg). 
 
Table 5 
Differences in Muscle Mass and Strength Based on Gender (n = 31) 
              Male                 Female  
                                                    M  SD M SD      t                  p                 
SM        22.27    6.9 15.56 2.84 3.9*            =.001* 
GS        21.78 4.32 10.82  2.5 8.901*        <.001* 
*p< .05 
Note: SM: Total Skeletal Muscle Mass (kg), GS: Grip Strength (kg).  
 
 
Description of Muscle Function 
 
Gait speed, repeated chair rise, SPPB, TUG and weight corrected jump power were used 
to assess muscle function. Mean score of 4-m gait speed was 0.65 m/s (SD = 0.18), repeated 
chair rise was 17.28 s (SD = 5.83), SPPB was 6.35 (SD = 2.69), TUG was 18.31 s (SD = 7.58), 
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and weight corrected jump power was 8.56 W/kg (SD = 5.51). Based on the established cut-off 
points for gait speed by the European Working Group on Sarcopenia in Older People 
(EWGSOP) (Cruz-Jentoft et al., 2010); 24 (77.4%) individuals had slow gait speed. Based on the 
established cut-off points for SPPB (Guralnik et al., 2000), 18 (58.1%) individuals had low SPPB 
performance and 8 (25.8%) had intermediate SPPB performance. Only 5 (16.1%) individuals had 
high performance. The results are detailed in Table 6. 
Men generated significantly higher weight corrected jump power than women. The mean 
score of weight corrected jump power for men was 12.06 w/kg (SD = 5.97) and 7.29 w/kg for 
women (SD = 4.87); t(28) = 2.234, p = .034. Men had numerically higher mean measurements 
than women for gait speed 0.67 (SD = 0.18) vs. 0.65 (SD = 0.18) m/s. Men also performed better 
than women on repeated chair rise 15.5 (SD = 6.43) vs. 17.9 (SD = 5.69) s and TUG 15.82 (SD = 
5.95) vs. 19.21 (SD = 8.01) s. Women had greater mean of SPPB score 6.36 (SD = 2.48) than 
men 6.33 (SD = 3.32). However, these differences were not statistically significant (Table 7). 
Table 6 
Description of Muscle Function 
Classification M SD n % 
Chair rise   17.28 5.83 24  
TUG  18.31 7.58 31  
Weight corrected jump power   8.56 5.51 30  
Gait speed 
≤ 0.8 m/s  
            > 0.8 m/s 
0.65 0.18 31 
24 
7 
 
 77.4 
22.6 
SPPB 
0-6 
7-9 
           10-12  
6.35 2.69 31 
18 
8 
5 
 
58.1 
25.8 
16.1 
Note: Chair rise and Timed Up and Go (TUG) are measured by second (s), Weight corrected jump 
power is measured by Watt/kg, Gait speed is measured by meter/second (m/s), Gait speed score > 0.8 
m/s = slow gait speed, Gait speed score ≤ 0.8 m/s = fast gait speed, SPPB: Short Physical Performance 
Battery. 
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Table 7 
 Differences in Muscle Function Based on Gender 
 Males (n=8) Females (n=22)   
 M SD M SD t p 
Gait speed  0.67 0.18 0.65 0.18 .292 .772 
Chair rise** 15.5 6.43 17.9     5.69 .868 .395 
SPPB 6.33 3.32 6.36 2.48 .028 .978 
TUG  15.82 5.95 19.21 8.01 1.089 .286 
Weight corrected jump 
power*** 
12.06 5.97 7.29 4.87 2.234 .034* 
*p< .05, **n=24, ***n=30 
Note: Gait speed is measured by meter/second (m/s), Chair rise and Timed Up and Go (TUG) are 
measured by second (s), SPPB: Short Physical Performance Battery, Weight corrected jump power is 
measured by Watt/kg. 
 
Relationship Between Muscle Outcomes and Self-Efficacy, Depression, and Social Support 
 
Self-efficacy for exercise, depression, and social support were dichotomized. Groups 
were created for self-efficacy based on the mean score. Depression and social support were 
grouped based on the established cut-off points (Allen & Annells, 2009; Marc et al., 2008; 
Lubben et al., 2006). The SM, GS, gait speed, repeated chair rise, SPPB, TUG, and jump power 
were examined as continues variables. T-tests were performed to examine the differences in 
muscle outcomes (i.e., SM, GS, gait speed, repeated chair rise, SPPB, TUG, jump power) based 
on self-efficacy, depression, and social support. No significant differences were found in muscle 
outcomes based on self-efficacy (Table 8) and social support (Table 10). There was a significant 
difference in chair rise time based on depression (t(22) = 2.597, p = .016). Subjects without 
depressive symptoms completed the five repeated chair rises faster than subjects with depressive 
symptoms. The mean score for subjects without depressive symptoms was 16.45 (SD = 5.34) and 
for subjects with depressive symptoms was 26.45 (SD = 0.47) (Table 9).  
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Table 8 
Differences in Muscle Outcomes Based on the Self-Efficacy 
 High self-efficacy Low self-efficacy   
 M SD M SD t p 
SM 18.10 5.13 16.87 5.55 .639 .528 
GS 14.94 5.91 13.00 5.94 .909 .371 
Gait speed  0.69 0.18 0.61 0.17 1.303 .203 
Chair rise* 15.70 5.88 19.49 5.26 1.623 .119 
SPPB 6.5 2.89 5.93 2.49 .841 .407 
TUG 17.35 5.43 19.39 9.57 .730 .471 
Weight corrected 
jump power** 
9.90 5.87 7.22 4.97 1.35 .188 
N=31, *n=24, **n=30 
Note: SM: Total Skeletal Muscle Mass (kg), GS: Grip Strength (kg), Gait speed is measured by 
meter/second (m/s), Chair rise and Timed Up and Go (TUG) are measured by second (s); SPPB: Short 
Physical Performance Battery, Weight corrected jump power power is measured by Watt/kg. 
 
Table 9 
Differences in Muscle Outcomes Based on Depressive Symptoms 
 Not depressed Depressed   
 M SD M SD t p 
SM 19.22 2.50 17.25 5.56 .689 .496 
GS 14.19 6.00 12.75 5.91 .447 .658 
Gait speed  0.67 0.18 0.53 0.10 1.460 .155 
Chair rise** 16.45 5.34 26.45 0.47 2.597 .016* 
SPPB 6.56 2.79 5.00 1.41 1.082 .288 
TUG 17.59 7.74 22.98 4.63 1.343 .190 
Weight corrected 
jump power*** 
8.86 5.70 6.61 4.16 .755 .456 
*p< .05, N=31, **n=24, ***n=30 
Note: SM: Total Skeletal Muscle Mass (kg), GS: Grip Strength (kg), Gait speed is measured by 
meter/second (m/s), Chair rise and Timed Up and Go (TUG) are measured by second (s); SPPB: Short 
Physical Performance Battery, Weight corrected jump power is measured by Watt/kg.. 
 
Table 10 
Differences in Muscle Outcomes Based on Social Support 
 Not socially isolated Socially isolated   
 M SD M SD t p 
SM 18.42 5.20 15.60 5.22 1.415 .168 
GS 14.33 6.53 13.30 4.57 .449 .657 
Gait speed  0.7 0.20 0.63 0.17 1.055 .300 
Chair rise* 16.60 5.44 17.70 6.20 .442 .663 
SPPB 7.0 2.63 6.05 2.73 .919 .366 
TUG 19.00 8.24 16.92 6.18 .703 .488 
Weight corrected 
jump power** 
9.89 4.30 7.90 6.02 1.044 .307 
N=31, *n=24, **n=30 
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Note: SM: Total Skeletal Muscle Mass (kg), GS: Grip Strength (kg), Gait speed is measured by 
meter/second (m/s), Chair rise and Timed Up and Go (TUG) are measured by second (s); SPPB: Short 
Physical Performance Battery, Weight corrected jump power is measured by Watt/kg. 
 
Graphical Presentation of the Differences  
 
Figure 5 graphically presents the mean scores of muscle mass, strength, and function 
based on the dichotomized groups of self-efficacy, depression, and social support. The figure 
suggests that there is a trend for subjects with higher self-efficacy scoring better on all 
measurements than the subjects with lower self-efficacy (Figure 5-A). There is also a trend for 
subjects without depressive symptoms scoring better on all measurements than the subjects with 
depressive symptoms. The figure suggests that there is a trend for subjects with strong social 
support scoring better on all measurements (except TUG test) than the subjects with weak social 
support. 
 
*Gait speed was scaled by a factor of 10 for the graph. 
**Lower scores in chair rise and TUG tests indicate better performance. 
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*Gait speed was scaled by a factor of 10 for the graph. 
**Lower scores in chair rise and TUG tests indicate better performance. 
(B) 
 
*Gait speed was scaled by a factor of 10 for the graph. 
**Lower scores in chair rise and TUG tests indicate better performance. 
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Figure 5. Graphical Presentation of the Differences in Muscle Outcomes Based on the IVs. Self-
efficacy (A), Depression (B), and Social support (C). 
 
Convergent Validity of Muscle Mechanography 
 
Convergent validity of MM was evaluated by examining the relationship between weight 
corrected jump power and grip strength, gait speed, chair rise, SPPB, and TUG tests. Pearson's 
product moment correlation coefficients were significant with each measure demonstrating 
convergent validity. Weight corrected jump power was significantly and positively correlated with 
GS, gait speed, and SPPB (r = .542, .716, and .777, respectively; p < .01). Weight corrected jump 
power was significantly and negatively correlated with chair rise and TUG (r = -.538 and -.638, 
respectively; p < .01). The results are detailed in Table 11. 
Table 11 
Correlation Coefficient Values Between Weight Corrected Jump Power, Muscle Mass, and Traditional 
Muscle Function Tests  
Measure  1 2 3 4 5 6 n 
1. SM -      31 
2. GS  .562** -     31 
3. Gait speed  .056 .172 -    31 
4. Chair rise -.113 -.213 -.652** -   24 
5. SPPB  -.123 .115 .787** -.726** -  31 
6. TUG  -.106 -.403* -.728** .606** -.633** - 31 
7. Weight corrected jump 
power 
.262 .542** .716** -.538** .777** -.638** 30 
*p< .05, ** p<.01 
Note: SM: Total Skeletal Muscle Mass (kg), GS: Grip Strength (kg), Gait speed is measured by 
meter/second (m/s), Chair rise is measured by second (s), SPPB: Short Physical Performance Battery, 
TUG: Timed Up and Go and is measured by second (s), Weight corrected jump power is measured by 
Watt/kg. 
 
Additional Findings 
 
Description of Muscle Strength Based on EWGSOP  
 
Participants were grouped into high and low grip strength based on the cut-off points 
established by the EWGSOP; the cut-off point for men is < 30 kg and for women < 20 kg (Cruz-
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Jentoft et al., 2010). Eighty-nine percent of men (n=8) had low GS and only one man (11%) had 
high GS. All of the women (100%) had low GS (Table 12). 
Table 12 
Description of Muscle Strength (n = 31) 
 
Measure 
n % M  SD 
GS 
Male  
<30 kg  
≥30 kg  
Female 
<20 kg 
≥20 kg 
31 
 
8 
1   
 
22  
0 
 
 
89 
11 
 
100 
0 
14 
21.78 
 
 
10.82 
5.91 
4.32 
 
 
2.5 
Note: GS: Grip Strength (kg). 
 
Differences in Muscle Mass, Strength, and Function Based on the Incidence of Fall    
 
An independent-samples t-test was conducted to compare mean scores of SM, GS, gait 
speed, chair rise, SPPB, TUG, and weight corrected jump power between individuals who had an 
incidence of fall in the past year and those who did not had an incidence of fall. A significant 
difference in the mean score of GS between individuals who did not had an incidence of fall (M 
= 15.67 kg, SD = 6.57) and individuals who had an incidence of fall (M = 11.7 kg, SD = 4.03); 
t(29) = 2.081, p = .047. The results are detailed in Table 13.   
Table 13 
Differences in Fall Incidence Based on Muscle Mass, Strength, and Function 
     _____Falls___          ___No Falls___  
 M SD M SD         t                p 
SM 16.47 4.79 18.25 5.63     0.925        .363 
  GS 11.7 4.03 15.67 6.57     2.081        .047* 
Gait speed 0.67 0.23 5.94 2.6      0.34        .738 
Chair rise** 15.52 5.90 18.53 5.65     1.263        .225 
SPPB 6.92 2.84 5.94 2.58     0.999        .326 
TUG 19.1 10.02 17.69 5.28     0.499        .622 
Weight corrected jump 
power*** 
7.64 5.09 9.27 5.87     0.793        .434 
*p< .05, N = 31, **n=24, n=30*** 
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Discussion 
 
Little is known about the characteristics of muscle function and the association between 
cognitive and psychosocial factors and sarcopenia among older adults, particularly those who 
live in RCACs. This study described the muscle outcomes of older adults living in one RCAC 
and examined the relationship between self-efficacy for exercise, depression, and social support 
and muscle outcomes, including muscle mass, strength, and function. This study showed that the 
participants had poor muscle mass, strength, and function. Values of muscle outcomes were 
numerically lower in comparison with the values observed in most of other studies (Dietzel, 
Gast, Heine, Felsenberg, & Armbrecht, 2013; Tsubaki, Kubo, Kobayashi, Jigami, & Takahashi, 
2009; Siglinsky et al., 2015). This is might due to fact that this study included frail and very old 
adults. The variability of inclusion and exclusion criteria across studies may also have an 
important impact on the findings. For instance, several studies included young individuals and 
excluded individuals with walking aids, those were unable to climb a standard staircase or unable 
to walk 800 m unaided, and those with any impairment of activities of daily living (Dietzel et al., 
2013; Tsubaki et al., 2009; Siglinsky et al., 2015). Accordingly, it is not surprising that the 
included sample had low muscle mass, strength, and function scores as this study represented a 
vulnerable and understudied population. 
A sex difference exists for muscle mass, grip strength, and Weight corrected jump power. 
Consistent with previously published values among community-dwelling older adults (Janssen, 
Heymsfield, Wang, & Ross, 2000; Yorke, Curtis, Shoemaker, & Vangsnes, 2015), men 
demonstrated significantly higher mean skeletal muscle mass and hand grip strength than 
women. Similar to previous study, the results also showed that men had significantly greater 
Note: SM: Total Skeletal Muscle Mass (kg), GS: Grip Strength (kg). 
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weight corrected jump power compared to women (Siglinsky et al., 2015). Although men 
performed slightly better than women on gait speed, chair rise, and TUG tests, women had 
slightly higher SPPB score than men. However, these differences were not statistically 
significant. These results are parallel to the available conflicting data regarding sex differences 
and physical function tests among community-dwelling older adults (Cooper et al., 2011; Fragala 
et al., 2012, Siglinsky et al., 2015). 
While the study did not demonstrate significant associations between self-efficacy for 
exercise and muscle outcomes, the results showed a trend for individuals with high self-efficacy 
to have better scores on all muscle mass, strength, and function measurements than those with 
low self-efficacy. This trend is similar to results from a previous study that found an association 
between self-efficacy and physical function in older adults (Cooper, Huisman, Kuh, & Deeg, 
2011). Self-efficacy is a main determinant of exercise and physical activity behaviors (McAuley 
et al., 2006), which both are among the most effective interventions to combat sarcopenia and 
functional limitations in older adults (Pillard, et al., 2011; Keysor, 2003; Morley, 2012). Despite 
the suggested protective effect of physical activity on muscle outcomes, physical activity 
behaviors and the practicality of exercise among older adults are remain questionable (Pillard et 
al., 2011). This is due to the different characteristics of older adults, including different levels of 
self-efficacy and outcome expectations as well as the physical, mental, and environmental 
obstacles. These barriers are considered a challenge for researchers and clinicians to help older 
adults to engage in or to increase physical activity or exercise (Lee, Arthur, & Avis, 2008). 
Addressing these aspects may maximize the effect of physical activity or exercise on muscle 
outcomes and prevent the onset or progression of sarcopenia among older adults. 
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Depressive symptoms were only significantly associated with poor performance on chair 
rise test. Besides, the results showed that individuals without depressive symptoms had greater 
muscle mass and strength, higher jump power, and better scores on the muscle function tests. 
Few previous studies have examined the association between depression and sarcopenia. Hsu 
and colleagues conducted a study among older men living in a retirement community and 
reported that older adults with depressive symptoms were significantly lower in muscle mass, 
strength, and function and had more physical dependence than those without depressive 
symptoms (Hsu et al., 2014). Kim and colleagues found similar results and reported a lower 
skeletal muscle mass in participants with depressive symptoms (Kim et al., 2011). Nevertheless, 
the latest report from Byeon and colleagues did not identify an association between depressive 
symptoms and muscle mass, strength, and function (Byeon et al., 2016). Although the 
association between sarcopenia and depression appeared inconsistent from the data of the latest 
observational studies, the findings of this study added to the growing evidence that depression 
can be a risk factor for sarcopenia. 
This study did not find significant associations between social support and muscle mass, 
strength, and function. However, the findings showed that individuals with strong social support 
system had greater muscle mass and strength and performed better on the muscle function tests 
(except for TUG test) than those who were classified as socially isolated. These findings are 
congruent with previous study that found a significant association between poor social support 
and low grip strength (Lamarca et al., 2013), which is a major component of sarcopenia (Fielding 
et al., 2011). Research indicated that strong social support is a protective factor in physical 
function incapacity, as well as it impacts the level of physical activity and physical health in 
older adults (Golden, Conroy, & Lawlor, 2009; Seeman, & Chen, 2002; Gallant, 2003; Wallace 
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et al., 2015; Yeom et al., 2008; Resnick, Orwig, Magaziner, & Wynne, 2002; Molloy, Dixon, 
Hamer, & Sniehotta, 2010). These findings suggest that social support may be a countermeasure 
against the adverse impact of physical inactivity on muscle outcomes, including muscle mass, 
strength, and function.  
The study also examined the convergent validity of MM relative to the traditional muscle 
function and strength tests (i.e., gait speed, chair rise, SPPB, grip strength). MM can quantitively 
measure the muscle function parameters including muscle power. The two-leg countermovement 
jump test is the most widely used test to assess muscle power (i.e., weight corrected jump power). 
The main findings in this study demonstrated convergent validity across all the included 
measures of muscle function and strength in this study. Weight corrected jump power was 
significantly and positively correlated with GS, gait speed, and SPPB (r = .542, .716, and .777, 
respectively; p < .01). Weight corrected jump power was also significantly and negatively 
correlated with chair rise (r = -.538 and -.638, respectively; p < .01).  
The findings from this study are congruent with results from previous studies that have 
compared weight corrected jump power with traditional muscle function and strength tests 
(Rittweger et al., 2004; Siglinsky et al., 2015). Siglinsky and colleagues reported a correlation 
between weight corrected jump power and grip strength, as well as between weight corrected jump 
power and gait speed, chair rise, and total SPPB score (Siglinsky et al., 2015). Another study 
showed high correlation between weight corrected jump power and gait speed, chair rise, and TUG 
(Rittweger et al., 2004). However, Rittweger and colleagues reported higher associations than 
those found in this study (Rittweger et al., 2004). This might be related to the fact that they 
recruited healthy individuals. Overall, these findings are consistent with the results from this 
study that weight corrected jump power correlates with traditional muscle function tests. 
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Previous research revealed that weight corrected jump power was best correlated with age 
and it is possible that MM may be superior to traditional tests at quantifying muscle function in 
older adults because of its higher correlation with age and good correlation with traditional 
muscle function tests and measured lean mass (Siglinsky et al., 2015). These results add to the 
clinical validity of MM and could potentially lead to greater sensitivity to change when 
monitoring exercise interventions in older adults. MM can be also useful in obtaining precise 
measures of muscle function and benchmarks for functional data among older adults. 
Limitations 
 
The study has several limitations including study design, sample size and methods. 
Causality cannot be inferred when descriptive-correlational study designs are used. A small 
convenience sample from one geographic region was utilized for this study so the findings may 
not be generalizable. The small sample size and inferential analyses used may have caused 
limited statistical power and led to a Type II error. In addition, there was a lack of control for all 
potentially confounding variables. Although pain was examined as a confounding variable, many 
other potentially confounding variables in this study were not controlled for and therefore the 
generalizability is limited and the results should be viewed with caution. Individuals with end-
stage organ disease, cognitive impairment, recent injury or surgery that limits ability to move 
around, and those who were unable to stand without assistance were excluded. This limits 
generalizability to a broader population and the findings should be viewed with caution. 
Another limitation is the use of muscle function tests (i.e., SPPB, TUG) presents some 
drawbacks mainly due to dichotomous (yes/no) determinations and being prone to human errors 
as the results depend on the times taken by individual examiners. Furthermore, although BIS is 
inexpensive, noninvasive, and well correlate with MRI and DXA predictions, the use of BIS to 
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assess muscle mass has a limitation. Due to the common problem of dehydration in older adult 
patients, BIS underestimates fat tissue, resulting in artificially high fat-free mass values. In 
addition, although self-efficacy, depression, and social support were measured using validated 
scoring systems, the results may not be robust since they are limited to only one time 
measurement. Finally, the convergent validity of MM was tested in a homogeneous small group 
of older adults living in one RCAC and the results must be reviewed with caution. 
Implications and Recommendation for Future Research 
 
The findings from this study have important implications for the identification of 
sarcopenia and for nursing practice. The findings show that RCACs residents have poor muscle 
outcomes, including muscle mass, strength, and function. This vulnerable population should be 
the target of assessment and prevention strategies to attenuate the frequently reported declines in 
physical function and muscle outcomes. In addition, the study supports the evidence that 
sarcopenia is not only related to the ageing processes; there are several modifiable factors that 
may be important in the onset and progression of sarcopenia. Findings from the current study 
suggest that self-efficacy, depression, and social support may be modifiable factors associated 
with poor muscle outcomes. This may emphasize the importance of health promotion earlier in 
life and prevention planning to prevent sarcopenia and maintain better muscle mass, strength, 
and function.  
Physical activity and exercise are among the most beneficial interventions for preventing 
sarcopenia and ameliorating muscle outcomes (Bruyère et al., 2016; Cruz-Jentoft et al., 2010; 
Pillard et al., 2011). Improving physical activity and exercise behaviors can be achieved through 
alleviating depressive symptoms and enhancing self-efficacy and social support (Resnick et al., 
2002). This suggests interventions to improve physical activity and exercise behaviors among 
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older adults should incorporate depression management and social support to strengthen self-
efficacy and outcome expectations related to physical activity and exercise. Improving 
depressive symptoms also minimizes the negative impact of depression on muscle outcomes in 
older adults (Pillard et al., 2011; Schaap, Pluijm, Deeg, & Visser, 2006).  
Nurses should play a major role in identifying those with poor muscle outcomes and 
improving physical activity and exercise behavior by providing frequent expert support and 
implementing self-efficacy-based interventions. Nurses should also employ new technology such 
as MM to predict the onset of physical function decline and evaluate the potential effect of 
nursing therapeutic interventions on muscle outcomes. 
Finally, future longitudinal studies with large sample sizes are required to confirm the 
association between the studied variables and to examine other potential lifestyle behaviors that 
might contribute to sarcopenia and its reversibility. Such studies provide a rationale for the 
development and evaluation of effective, feasible, transferable and sustainable interventions 
implemented in RCAC settings. Finally, future research is needed to provide evidence about the 
validity of MM and its ability to identify small changes in older adults with a wide range of 
performance, as well as to examine whether MM is associated with geriatric outcomes such as 
sarcopenia, falls, and fractures. Such evidence supports the sensitivity of this methodology to 
intervention-induced changes in muscle function and the possibility of using MM in the clinical 
and research evaluation of sarcopenia among older adults. 
Conclusion 
 
Sarcopenia is major health problem among the aging population worldwide. This study is 
only one of a few to evaluate the relationship between selected cognitive and psychosocial 
factors and sarcopenia among older adults living in RCACs. The study suggests that RCACs 
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have poor muscle mass, strength, and function. The findings support the hypothesis that 
depressive symptoms are associated with poor muscle function. The study also shows that the 
decline in muscle mass, strength, and function is seen more frequently in individuals with low 
self-efficacy level and poor social support. In addition, this study provides a new evidence about 
MM as a new technology to quantitively assess muscular function in older adults, potentially 
making this a valuable research tool.  
Chapter Summary 
 
This chapter reported the design, methods, sample, and setting of the study. The findings 
about self-efficacy for exercise, depression, social support, and muscle characteristics of RCACs 
residents, as well as the findings on the associations between the variables were presented. 
Limitations, implications, and recommendations for future research were discussed. The findings 
of this cross-sectional descriptive correlational study filled gaps in knowledge and contributed to 
the literature on risk factors for sarcopenia in older adults living in RCACs, and provided 
information about MM as a novel method to evaluate muscle function in older adults. 
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CHAPTER 5 
 
Chapter Introduction 
 
This chapter is focused on discussing the findings of the study. A discussion of how the 
specific findings are consistent with the adapted theoretical framework, and other research 
findings are presented. The limitations of the study and implications for nursing practice, health 
policy and education are discussed. Recommendations for future research and a concluding 
statement are presented. 
Synthesis of Findings 
 
Sarcopenia is a geriatric syndrome characterized by a reduction in muscle mass, strength, 
and function. This syndrome is highly prevalent and associated with functional decline and loss 
of independence in older adults. Understanding the etiology and risk factors of sarcopenia is an 
essential step towards the development of new methods for clinical diagnosis, new insights into 
the underlying mechanisms, and ultimately to the development of effective interventions for 
sarcopenia prevention and management. The findings of this study indicate that older adults 
living in RCACs have lower values of muscle mass, strength, and function in comparison with 
other values observed in many other studies (Dietzel et al., 2013; Siglinsky et al., 2015; Tsubaki 
et al., 2009). This indicates that this group of older adults may be at greater risk for negative 
health consequences than community dwelling older adults, such as fall, fractures, and being 
placed in more restricted living environment including nursing homes. 
Consistent with other literature, findings from this study shows a trend for individuals 
with high self-efficacy, without depressive symptoms, and with strong social support to present 
greater muscle mass, strength, and function (Hsu et al., 2014; Kim et al., 2011; Lamarca et al., 
2013). While there is no research to date that examines d the association between self-efficacy 
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for exercise and sarcopenia, other studies found that self-efficacy is a key predictor for physical 
activity and exercise, both of which countermeasure functional decline and poor muscle 
outcomes (Keysor, 2003; McAuley et al., 2006; Pillard, et al., 2011). Several studies also 
demonstrate relationship between depressive symptoms and social support and muscle outcomes 
(Hsu et al., 2014; Kim et al., 2011; Lamarca et al., 2013). These findings highlight the 
importance of further exploring the examined factors and addressing them in future interventions 
to prevent, maintain, and improve muscle outcomes and functional capacity among older adults, 
particularly RCACs residents. 
In addition, the development of interventions to mitigate sarcopenia and functional 
decline requires sensitive and reproducible testing methodologies. Similar to other studies, the 
current study provides new evidence about the validity of MM as a novel method to quantitively 
assess muscle function parameters in older adults. MM is found to be safe, valid, and sensitive 
method with greater ability to detect small changes in muscle function among older adults in 
comparison to the traditional muscle function tests such as gait speed and SPPB (Buehring et al., 
2015; Siglinsky et al., 2015; Taani et al., 2017). Using such technology with good reproducibility 
and sensitivity could be useful in assessing for sarcopenia, evaluating the effectiveness of 
nursing intervention, and extending the nursing science.  
Implications for Nursing Theory 
 
Findings from the study show that older adults without depressive symptoms and with 
high self-efficacy and social support have greater muscle mass, strength, and function (although 
self-efficacy and social support were not significant). These findings are consistent with the 
adapted Individual and Family Self-Management Theory (IFSMT) framework (Ryan & Sawin, 
2009) which suggests that context factors (e.g., depression and social support) and the self-
 92 
 
management process (e.g., self-efficacy) may contribute to better self-management behaviors 
(physical activity, exercise, and healthy eating habits), and lead to improved health outcomes 
(better muscle mass, strength, and function). The findings from this study suggest that addressing 
the examined risk factors could be a helpful intervention for improving muscle outcomes among 
older adult living in RCACs. 
The IFSMT could be used to provide theory-informed nursing interventions to improve 
muscle outcomes and prevent sarcopenia. Individual and family-centered interventions impact 
self-management behaviors addressing either the context or the self-management process. While 
interventions focused on the contextual factors can reduce risk or foster conditions that support 
self-management, interventions aimed at the self-management process can enhance knowledge 
and beliefs and increase the use of self-regulation behaviors. The findings from this study 
suggest that future research should focus on interventions to improve engaging in physical 
activity and exercise programs, managing depression, and developing a strong social network. 
These factors may play a role in RCACs residents’ attitudes influencing their healthy behaviors 
including physical activity, exercise, and eating habits and ultimately their muscle outcomes.  
Incorporating the concepts and assumptions of the IFSMT helped examine potential risk 
factors for sarcopenia from a nursing perspective. Nonetheless, the adapted theoretical 
framework used to guide this study is not yet comprehensive or final. The author suggests 
considering the adapted theoretical framework as a foundation for future nursing research. 
Nurses are encouraged to validate the findings of this study and generate empirical evidence on 
the relationship between the studied variables utilizing theory-testing approach. Continued use 
and testing of the IFSMT could result in expanding nursing knowledge related to self-
management in older adults with sarcopenia and functional decline, as well as revealing concepts 
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essential to self-management and determining what concepts are applicable for sarcopenia 
among older adults. 
Implications for Education, Clinical Practice, and Policy 
 
Implications for Nursing Education 
 
Evidence from previous research revealed that providing care for older adults by 
healthcare professionals prepared in geriatrics leads to improvements in health outcomes, 
including better physical, functional, and psychosocial well-being without an increase in 
healthcare costs (Kovner, Mezey, & Harrington, 2002). Such improvement in health outcomes 
may also reduce cost. Therefore, increasing the geriatric content in undergraduate nursing 
curriculum could be a helpful strategy to raise awareness among nurses about chronic conditions 
in older adults and provide quality nursing care for older adults. Geriatric certifications and 
education programs should be offered to nurses to provide them with knowledge and skills 
required to assess and manage chronic conditions including sarcopenia and functional loss and to 
provide the highest quality care possible for their patients. More research is needed to determine 
if these educational initiatives actually improve patient outcomes and reduce cost. 
The role of the nurse in disease prevention continues to be of utmost importance. Self-
management is a crucial aspect to quality living and successful prevention and management of 
chronic conditions. The American Association of Colleges of Nursing (AACN) created the 
Essentials of Baccalaureate Education for Professional Nursing Practice document to disclose the 
important curricular elements and framework for developing the undergraduate nursing 
curriculum for the 21st century (AACN, 2008). The document emphasized the importance of 
integrating disease prevention and health behavior change theories into nursing courses.  
Following these recommendations, nursing courses should be modified regularly to reflect the 
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current evidence-based self-management practice. The findings from this study can be used as an 
example to educate nursing students about the IFSMT, implications and ramifications of poor 
muscle outcomes, possible risk factors for sarcopenia, and how to promote self-management 
behaviors among their patients. 
Implications for Clinical Practice 
 
Nurses have a broad scope of practice that plays a significant role in improving patients' 
knowledge, behavior change, and health outcomes. Nurses are likely to encounter older adults 
with sarcopenia and functional decline in hospitals, nursing homes, assisted-living facilities, and 
in their own homes. Nurses are expected to develop holistic care plans to prevent sarcopenia and 
improve physical function and overall well-being of older adults. However, research shows that 
the routine assessment for sarcopenia is lacking and sarcopenia is commonly underdiagnosed and 
undertreated (Giuliani et al., 2008; Iolascon et al., 2014; Roberts et al., 2013; Zacker, 2006).  
Assessment for sarcopenia and targeting older adults at high risk may be an important 
first step to prevent and manage functional decline (Beaudart et al., 2016; Fielding et al., 2011). 
Nurses have a significant role in identifying patients who are at risk for sarcopenia and 
functional decline, implementing nursing preventive measures, and referring them to specialists 
in the field (Hunt, Chapa, Hess, Swanick, & Hovanec, 2014; Zacker, 2006). This study provides 
information about risk factors for sarcopenia and encourage nurses to incorporate methods for 
screening such as gait speed and grip strength. The Red Flag and SARC-F questionnaires could 
also be useful to quickly and easily screen older adults for sarcopenia and functional decline 
during a standard health care (Beaudart et al., 2016; Cruz-Jentoft et al., 2014; Fielding et al., 
2011). Integrating sophisticated methods such as MM in the clinical setting may be helpful to 
assess muscle function and detect those at risk for sarcopenia.  
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Patient-centered interventions such as motivational interviewing and collaborative goal 
setting were not examined in this study but may be helpful modalities to improve healthy 
behaviors. Motivational interviewing and collaborative goal setting may encourage patients to 
determine what changes are necessary - such as engaging in physical activity, improving 
nutritional intake, managing depression, and improving social support network - and how they 
can be achieved (Britt, Hudson, & Blampied, 2004; Handley et al., 2006). Nurses should also 
identify both individual and contextual health risk factors that hinder the capacity of older adults 
to promote their health behaviors. In addition, hospitalization leads to sarcopenia among older 
adults due to an increased inflammatory burden, malnutrition, and bed rest-related muscle disuse 
(Welch, Hassan-Smith, Greig, Lord, & Jackson, 2017). Nurses must take a lead role in 
prevention of sarcopenia and functional decline in hospitalized older adults through identifying 
patients at risk, mobility assessments, initiating exercises, managing malnutrition, and early 
mobilization. These practices may reduce the length of stay, hours needed to provide care, and 
adverse outcomes related to poor muscle outcomes and loss of functional capacity. 
Implications for Health Policy 
 
Preventing and managing sarcopenia require policy solutions and a wide range of 
interrelated programs and actions from both the public and private sectors. Using results from 
this study and other research on sarcopenia to raise awareness about risk factors for sarcopenia, 
its impact on health and well-being, and the importance of healthy lifestyles is a crucial step to 
prevent sarcopenia and ensure good muscle outcomes among older adults. Because the most 
effective approach to prevent sarcopenia is to promote physical activity, exercise, and proper 
nutrition (Cruz-Jentoft et al., 2010; Morley, 2012;  Rom, Kaisari, Aizenbud, & Reznick, 2012), 
factors including the self-management behaviors in older adults’ population and the lack of 
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resources for exercise programs and appropriate nutrition should be a major concern for policy 
makers. Public policy should focus on increasing accessibility to public exercise facilities at little 
or no cost; implementing therapeutic foods supplementation solutions to reverse undernutrition; 
and providing health promotion and mental health counseling services (Bruyère et al., 2016; 
Rom et al., 2012). 
Stakeholders from public health authorities, healthcare organizations, academia, research 
centers, consumers, and aging associations across the country should begin a national dialogue to 
discuss the importance of preventing sarcopenia and functional decline in older adults. 
Stakeholders should make an effort to secure funding and resources for future research, as 
sarcopenia is still relatively a new area of research. Supporting research in this area is crucial to 
better understand the etiology of sarcopenia and functional decline, establish standardized 
methodology for clinical assessment, and develop new intervention strategies. Furthermore, new 
policies are needed to tackle sarcopenia and functional decline upstream and to shift from 
reactive repair to proactive prevention paradigm (Mazières et al., 2017). These policies should 
include implementing a comprehensive care model for prevention of sarcopenia and functional 
decline in the clinical settings and long-term care facilities and offering interventions that are 
multidisciplinary, integrated and goal-oriented at the physical, social, and psychological domains 
of functional decline. 
Limitations 
 
Several limitations should be considered while interpreting the findings from this study. 
A cross-sectional descriptive correlational design was used, and therefore the results cannot be 
used to make causal claims among relationships of sarcopenia and the hypothesized associated 
factors. The study was focused on a small convenience sample from one RCAC and individuals 
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with end-stage organ disease, recent injury or surgery, cognitive impairment, and those who were 
unable to stand without assistance were excluded. Therefore, the findings should not be 
generalizable to nursing home residents or healthy community-dwelling older adults and should 
be viewed with caution. The small sample size and statistical analysis techniques used in this 
study may have caused limited statistical power and led to a Type II error 
Although pain was examined as a confounding variable, many other potentially 
confounding variables including current medical condition, severity of illness, and comorbidities 
were not controlled for. Thus, the generalizability is limited and the results should be viewed 
with caution. The study also has some measurement limitations. First, using the traditional 
muscle function tests (i.e., SPPB, TUG) presents some shortfalls mainly due to dichotomous 
(yes/no) determinations and being prone to human errors. Second, the use of BIS for muscle 
mass assessment has a limitation due to the dehydration problems usually observed in older 
adults, which may result in an underestimation of the fat tissue and an overestimation of fat-free 
mass. However, BIA is inexpensive, easy to use, reproducible, and considered as a portable 
alternative to DXA and MRI. Third, measuring self-efficacy, depression, and social support is 
limited to only one time measurement and future studies could use repeated measures for more 
robust findings. Finally, the convergent validity of MM was tested in a homogeneous small 
group of older adults living in one RCAC and the results must be interpreted with caution. 
Recommendation for Research 
 
Understanding the risk factors for sarcopenia and functional decline in RCACs residents 
has implications for future nursing research that could bridge the gap between research-generated 
evidence and nursing care. The findings from this study show a trend for individuals with high 
self-efficacy, without depressive symptoms, and with strong social support to present greater 
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muscle mass, strength, and function. Future longitudinal studies with large sample sizes are 
required to confirm the association between the studied variables and to examine other potential 
lifestyle behaviors that might contribute to sarcopenia and its reversibility. 
While self-management interventions are commonly complex with multiple components, 
the feasibility of these interventions should be investigated, particularly among RCACs 
residents. Such interventions could improve self-management behaviors and physical function 
and prevent sarcopenia in older adults. Testing the effect of variety of exercise programs, such as 
group-based exercise and vibration exercise, on physical function and muscle outcomes is also 
recommended. Measurement methods such MM can be used to evaluate the effectiveness of 
nursing interventions on physical function and muscle outcomes among older adults. Although 
the available results from several studies demonstrate the safety, practicality, and validity of 
MM; it’s valuable to conduct future research to confirm these findings and to examine whether 
MM is associated with geriatric outcomes such as sarcopenia, falls, and fractures.  
The recruitment process of the population of older adults, particularly RACAs residents 
can be lengthy and exhausting. In the original study, the author collaborated with social workers, 
physical therapists, and registered nurses who worked within the facility to recruit the greatest 
possible number of subjects and to ensure successful recruitment of the most representative 
sample of subjects. Another recommendation is to recruit from multiple facilities to reach the 
target sample size and to ensure sample representativeness. In addition, several strategies were 
used in the original study to reduce burden on the participants, including administering the 
questionnaire by interview, assessing whether the older adult is fatigued and wants to finish the 
questionnaires or muscle function tests after a one hour break or on another day. Both strategies 
were found to be effective in reducing the burden on the participants.  
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Conclusion 
 
Sarcopenia, the decline in muscle mass, strength, and function, is associated with 
functional loss and disability among older adults. The findings show that RCACs residents have 
poor muscle outcomes, which may affect their everyday functions and make them at high risk for 
falls and fractures. The poor muscle outcomes are also seen more often in those with depressive 
symptoms and low self-efficacy and social support. These contextual and self-management 
process-related factors may have important roles in the development of sarcopenia. The study 
also provides evidence about the validity of MM as a tool to quantitively assess muscle function 
in older adults. Such tools can also be used in research setting to assess the effect of nursing 
intervention on muscle outcomes. 
Chapter Summary 
 
The current study revealed that older adults living in RCACs have low muscle outcomes, 
and these poor outcomes are more prevalent in individuals with depressive symptoms and with 
low-self-efficacy and social support. Nurses has the responsibility to take a lead role in the 
prevention of sarcopenia and functional decline in older adults through individual-centered care, 
education, and motivation. Nurse educators are also encouraged to improve the quality of 
nursing education by integrating geriatric content to meet the health needs of the growing 
population of older adults. Moreover, since chronic health conditions are highly prevalent among 
older adults such sarcopenia and functional loss, there is a necessity to design and develop 
nursing intervention to mitigate sarcopenia and improve physical function in older adults. MM 
can be integrated in designing and evaluating specific nursing interventions aimed at improving 
physical function and muscle outcomes in older adults. In summary, the results of this study 
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necessitate a broader examination of the risk factors for sarcopenia, exploring potential 
intervention modalities, and employing sophisticated methods in this area of research. 
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APPENDICES 
 
Appendix A: Studies Addressing the Risk Factors for Sarcopenia in Older Adults 
 
Author, 
Year 
 
Purpose Design, Sample 
Size, Age 
Measure Outcome Measure 
Alexandre 
et al. 
(2014) 
Examine the prevalence 
and factors associated with 
sarcopenia in community 
dwelling older adults 
Correlational, 
cross-sectional 
 
n = 1149 
 
≥ 60 years  
 
 
The Mini Mental State Exam 
(MMSE), the International 
Physical Activity Questionnaire 
(IPAQ), Geriatric Depression 
Scale (GDS), Mini-Nutritional 
Assessment (MNA), skeletal 
muscle mass index using the 
Lee equation, handgrip 
strength, and gait speed 
 
Cognitive impairment (OR 2.68, 
95% CI 1.23–5.84), lower income 
(OR 2.57, 95% CI 1.06–6.20), 
smoking (OR 2.00, 95% CI 1.11–
3.63), undernutrition (OR 11.54, 
95% CI 3.45–38.59) and risk for 
undernutrition (OR 3.15, 95% CI 
2.03–4.89) were factors 
associated with sarcopenia 
Byeon et al. 
(2016) 
Examine the relationship 
between sarcopenia and 
depression in community 
dwelling older adults by 
age group and obesity 
status 
Correlational, 
cross-sectional 
 
n = 7,364 
 
Age was 
categorized into 
three groups (20 
- 39, 40 - 59, 
and ≥ 60 years) 
Body Max Index (BMI), 
depressive symptoms, and 
appendicular skeletal muscle 
mass via Dual Energy X-ray 
Absorptiometry (DXA) 
No significant associations 
between sarcopenia and 
depression among all age groups  
 
Castillo et 
al. (2003) 
Examine the prevalence 
and factors associated with 
sarcopenia in community-
dwelling older adults 
Correlational, 
cross-sectional 
 
n = 1700 
 
65-98 year-old 
Medical conditions, medication 
use, Bioimpedance 
Spectroscopy (BIS), grip 
strength, alcohol intake, 
smoking status, physical 
activity level, and BMI 
Lack of physical activity and 
current smoking are risk factors 
for sarcopenia 
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Author, 
Year 
 
Purpose Design, Sample 
Size, Age 
Measure Outcome Measure 
Figueiredo 
et al. 
(2014) 
 
 
Analyze the prevalence of 
sarcopenia and associated 
risk factors in community-
dwelling older adults 
Correlational, 
cross-sectional 
 
n = 399 
 
Mean age = 74.2 
years 
 
Lifestyle, race, medical history, 
BMI, DXA 
 
BMI (OR 0.45, 95% CI 0.36–
0.57), black race (OR 0.27, 95% 
CI 0.08–0.88), current smoking 
(OR 3.44, 95% CI 1.18–9.96), 
physical activity (OR 0.28, 95% 
CI 0.08–0.95), and total femur 
bone mineral density (OR 0.019, 
95% CI 0.0003–0.98) were risk 
factors for sarcopenia 
Gariballa & 
Alessa 
(2013) 
Identify the clinical 
determinants and 
prognostic significance of 
sarcopenia 
in a cohort of hospitalized 
acutely ill older patients 
Correlational, 
cross-sectional 
 
n = 432 
 
 ≥ 65 years  
Medical conditions, history of 
chronic illnesses, smoking 
status, alcohol and drug intake, 
nutritional status, Barthel Index 
of Activities of Daily Living, 
muscle strength-hand grip, and 
muscle mass measured by mid-
arm muscle circumference 
 
Depression symptoms and lower 
serum albumin concentration 
were associated factors for 
sarcopenia 
Gianoudis 
et al. 
(2014) 
 
 
Examine the relationship 
between total sitting and 
TV viewing time on 
sarcopenia in community-
dwelling older adults 
 
Correlational, 
cross-sectional 
 
n = 162  
 
60 – 86 years 
Three repetition maximum 
testing 30 s sit-to-stand, four 
square step test, the timed-up-
and-go (TUG) test, timed stair 
climb test, and total sitting and 
TV viewing time via 
questionnaire 
 
Overall sitting time 1+hr/day the 
risk of sarcopenia increased by 33 
% (OR 1.33, 95% CI 1.05, 1.68) 
Han et al. 
(2016) 
Examine the prevalence 
and factors associated with 
sarcopenia in community-
dwelling older adults 
Correlational, 
cross-sectional 
 
n = 1,069  
Medical conditions, educational 
level, smoking and drinking 
habits, history of falls, physical 
Presence of sarcopenia was 
inversely associated with BMI for 
both sexes. Diabetes in males 
(OR 5.04, 95% CI 1.70–14.89), 
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Author, 
Year 
 
Purpose Design, Sample 
Size, Age 
Measure Outcome Measure 
 
≥ 60 years 
activity level, GDS, BIS, gait 
speed, and grip strength 
diabetes in females (OR 2.36, 
95% CI 1.06–5.25), daily 
consumption of alcohol (OR 
10.60, 95% CI 1.75–64.24), 
peptic ulcer in female (OR 5.58, 
95% CI 2.13–14.59) were 
associated risk factors for 
sarcopenia 
Hsu et al. 
(2014) 
 
 
 
Evaluate the association of 
cognitive impairment, 
depressive mood and 
sarcopenia among older 
men living in the veterans 
retirement community  
Correlational, 
cross-sectional 
  
n = 353 
 
≥ 65 years   
 
ADL, gait speed, handgrip 
strength, BMI, BIA, MMSE, 
and GDS 
Sarcopenia was associated with 
cognitive impairment (OR 3.03, 
95% CI 1.63–5.65) and 
depressive symptoms (OR 2.25, 
95% CI 1.03–4.89)  
Older adults with sarcopenia 
were significantly lower in BMI 
compared to those who did not 
have sarcopenia  
 
Kim et al. 
(2011) 
Examine the relationship 
between depression and 
various components of 
body composition, 
including fat and muscle, 
in community-dwelling 
older adults 
 
Correlational, 
cross-sectional 
 
n = 836  
 
≥ 60 years 
GDS, abdominal visceral fat 
area and subcutaneous fat area 
via Computed Tomography 
(CT), appendicular skeletal 
muscle mass via DXA 
Depression was associated with 
low BMI and sarcopenia. The 
risk of depression was lower with 
higher appendicular skeletal 
muscle mass (OR 0.49; 95% CI 
0.29–0.85) and lower with higher 
BMI (OR 0.70, 95% CI 0.51–
0.96). Depression was negatively 
associated with BMI in women 
(OR 0.73; 95% CI 0.56–0.95) 
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Author, 
Year 
 
Purpose Design, Sample 
Size, Age 
Measure Outcome Measure 
Landi et al. 
(2012)  
Evaluate the prevalence of 
sarcopenia and its 
association with functional 
and clinical status in 
nursing home residents 
Correlational, 
cross-sectional 
 
n = 122  
 
≥ 70 years  
ADL via Minimum Data Set 
assessment form for the nursing 
Home (MDS-NH), cognitive 
performance, BMI, gait speed, 
hand grip strength, and BIS 
Cerebrovascular disease (OR 
5.16, 95% CI 
1.03–25.87), osteoarthritis (OR 
7.24, 95% CI 2.02–25.95) were 
associated risk factors for 
sarcopenia. Risk of sarcopenia 
negatively associated with BMI 
>21kg/m2 (OR 0.76, 95% CI 
0.64-0.90), physical activity 
1+hr/day (OR 0.40, 95% CI 0.12-
0.98) 
 
Lau et al. 
(2005) 
 
Evaluate the prevalence of 
and risk factors for 
sarcopenia in community-
dwelling older adults  
 
Correlational, 
cross-sectional 
 
n = 527 
 
≥ 70 years 
medical conditions, DXA, 
alcohol consumption, smoking 
status, regular exercise, and 
BMI 
 
 
BMI < 18.5 was a significant risk 
factor for 
sarcopenia in men (OR 39.1, 95% 
CI 
11.3–134.6) and women (OR 9.7, 
95% CI 2.8–33.8) 
Lee et al. 
(2007) 
 
 
Examine the association 
between sarcopenia and 
common chronic illnesses, 
lifestyle factors, 
psychosocial well-being 
and physical performance 
in community-dwelling 
older adults 
 
Correlational, 
cross-sectional 
 
n = 4000  
 
  
 ≥ 65 years  
Medical illnesses, smoking 
status, alcohol consumption, 
Physical activity scale of the 
elderly (PASE), GDS, grip 
strength, timed chair-stands, 
gait speed, and DXA 
Sarcopenia was associated with 
cigarette smoking (OR -0.19, 
95% CI -0.31, -0.07), chronic 
illnesses (diabetes, hypertension, 
heart disease, COPD), 
underweight (OR -1.28, 95% CI -
1.47, -1.29), and physical 
inactivity (OR -0.27, 95% CI -
0.37, -0.17) 
 
Martins, 
Bôas, 
Identify the prevalence of Correlational, 
cross-sectional 
Socioeconomic and 
demographic status, 
Retirement (OR 2.165, CI:95% 
CI 1.037 - 4.250) and smoking 
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Author, 
Year 
 
Purpose Design, Sample 
Size, Age 
Measure Outcome Measure 
McLellan 
(2016) 
sarcopenia and its 
association with 
anthropometric and 
socioeconomic factors in 
older adult patients assisted 
by primary health care 
 
n = 136 
 
≥ 60 years 
anthropometric profile was 
assessed, BIS, grip strength, 
and dietary intake 
(OR 9.435, 95% CI 1.228 - 
72.499) were risk factors for 
sarcopenia 
Murphy et 
al. (2013) 
Examine the time course of 
sarcopenia and to 
explore potential 
determinants of transition 
between stages of 
sarcopenia in community-
dwelling older adults 
 
 
Correlational, 
retrospective, 
longitudinal 
study (9-year 
follow-up) 
 
n = 2928  
 
70 - 79 years 
 
DXA, gait speed, grip strength, 
BMI, physical activity level, 
pain, smoking status 
 
 
History of pain (OR 1.18, 95% CI 
1.01–1.39) and higher BMI (OR 
1.30, 95% CI 1.25–1.36) were 
predictive of transition from 
normal state into sarcopenic state 
Santos et 
al. (2015) 
 
 
Analyze whether 
sarcopenia is associated 
with sociodemographic 
factors and chronic 
noncommunicable diseases 
in community-dwelling 
older adults 
 
Correlational, 
cross-sectional 
 
n = 120  
 
80 – 95 years 
Education level, chronic 
noncommunicable diseases, 
ethnicity, BMI, and DXA 
Nutritional status (OR 5.14, 95% 
CI 1.94-13.57) was associated 
with sarcopenia 
 
Senior et al. 
(2015) 
 
 
Evaluate the prevalence 
and risk factors of 
sarcopenia among nursing 
home residents 
Correlational, 
cross-sectional 
 
n = 102 
 
≥ 60 years 
BIA, grip strength, gait speed, 
Short Physical Performance 
Battery (SPPB), MNA, GDS, 
MMSE, and IPAQ  
BMI (OR = 0.80, 95% CI 0.65–
0.97), low physical performance 
(OR 0.83, 95% CI 0.69–1.00), 
nutritional status (OR 0.19, 95% 
CI 0.05–0.68) and sitting time 
  
1
3
1
 
Author, 
Year 
 
Purpose Design, Sample 
Size, Age 
Measure Outcome Measure 
(OR 1.18, 95% CI 1.00–1.39) 
were risk factors for sarcopenia 
 
Tasar et al. 
(2015) 
 
 
Investigate the prevalence 
of sarcopenia and its 
influencing factors in the 
local elderly nursing home 
residents 
Correlational, 
cross-sectional 
 
n = 211 
 
≥ 65 years  
 
Smoking and alcohol intake 
status, medications use, number 
and types of chronic diseases, 
upper arm circumferences, 
BMI, SPPB, and BIS 
Malnutrition (OR 0.533, 95% CI 
0.292–0.974) and current 
smoking (OR 2.289, 95% CI 
1.063–4.929) were risk factors 
for sarcopenia 
Volpato et 
al. (2014) 
 
 
Estimate the prevalence 
and clinical correlates of 
sarcopenia in community-
dwelling older adults 
Correlational, 
cross-sectional 
 
n = 730  
 
≥ 65 years 
BIA, gait speed, smoking habit, 
education level, physical 
activity, nutritional status, 
comorbidities, Center for 
Epidemiologic Studies 
Depression scale, MMSE, and 
blood sample 
Lower insulin-like growth factor 
I (OR 3.89, 95% CI 1.03–14.1) 
and low bioavailable testosterone 
(OR 2.67, 95% CI 1.31–5.44) 
were associated with sarcopenia. 
A decreased probability of being 
sarcopenic was detected for 
individuals with higher level of 
education 
(OR 0.85, 95% CI 0.74–0.98). 
Nutritional intake, physical 
activity, and level of comorbidity 
were not associated with 
sarcopenia 
 
Yalcin et 
al. (2015) 
 
 
Evaluate the prevalence of 
sarcopenia and associated 
factors with sarcopenia 
among nursing home 
residents  
Correlational, 
cross-sectional 
 
n = 141  
 
Barthel Index of Activities of 
Daily Living, MMSE, MNA, 
BMI, handgrip strength, gait 
speed, BIS 
BMI was associated with 
sarcopenia (OR 2.91, 95% CI 
1.18-7.16) 
 
  
1
3
2
 
Author, 
Year 
 
Purpose Design, Sample 
Size, Age 
Measure Outcome Measure 
≥ 65 years 
Yu et al. 
(2014) 
Examined the incidence 
and the reversibility of 
sarcopenia and their 
associated factors over a 4-
year period in community-
dwelling older adults 
Correlational, 
cohort, 
longitudinal 
study (4-year 
follow-up) 
 
n = 4000  
 
≥ 65 years 
Medical conditions, dietary 
intake, education level, 
physical activity level, DXA, 
grip strength, and gait speed 
Stroke (OR 2.56, 95% CI 1.32–
4.95), Instrumental ADL 
impairment (OR 2.12, 95% CI 
1.49–3.02), COPD (OR 1.84, 
95% CI 1.02–3.31), BMI (OR 
0.66, 95% CI 0.62–0.70), 
physical activity (OR 0.995, 95% 
CI 0.991–0.999) were risk factors 
for sarcopenia 
- P < 0.05 is statistically significant 
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Appendix B: Short Physical Performance Battery (SPPB) Instructions 
 
 
Read the instructions that are in bold and italic aloud. 
This is a physical performance test that has three main components:  an 
assessment of balance, gait speed and chair rise time. 
General Notes: 
 If a patient is not able to complete a test, record the reason, stop the balance tests, 
and move on. 
 All tests are done with eyes open.  Patients can move their arms to stabilize, but can 
not grab onto any objects or people.  
 Walking aids are not permitted during the balance tests. 
1. BALANCE TESTS 
The patient must be able to stand unassisted without the use of a cane or walker. You may help 
the patient to get up.  
Now let’s begin the evaluation. I would now like you to try to move your body in 
different movements. I will first describe and show each movement to you. Then 
I’d like you to try to do it. If you cannot do a particular movement, or if you feel it 
would be unsafe to try to do it, tell me and we’ll move on to the next one. Let me 
emphasize that I do not want you to try to do any exercise that you feel might be 
unsafe.  
Do you have any questions before we begin? 
A. Side-by-Side Stand  
1. Now I will show you the first movement. 
2. (Demonstrate) I want you to try to stand with your feet together, side-by-side, for 
about 10 seconds. 
3. You may use your arms, bend your knees, or move your body to maintain your 
balance, but try  
not to move your feet. Try to hold this position until I tell you to stop. 
4. When the patient has his/her feet together, ask “Are you ready?”  
5. Then let go and begin timing as you say, “Ready, begin.” 
6. Stop the stopwatch and say “Stop” after 10 seconds or when the patient steps out of 
position or grabs your arm. 
7. If patient is unable to hold the position for 10 seconds, record result and move on. 
  
B. Semi-Tandem Stand  
1. Now I will show you the second movement. 
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2. (Demonstrate) Now I want you to try to stand with the side of the heel of one foot 
touching the big toe of the other foot for about 10 seconds. You may put either 
foot in front, whichever is more 
comfortable for you. 
3. You may use your arms, bend your knees, or move your body to maintain your 
balance, but try  
not to move your feet. Try to hold this position until I tell you to stop. 
4. When the patient has his/her feet together, ask “Are you ready?” 
5. Then let go and begin timing as you say “Ready, begin.” 
6. Stop the stopwatch and say “Stop” after 10 seconds or when the patient steps out of 
position or grabs your arm. 
7. If patient is unable to hold the position for 10 seconds, record result and go to the gait 
speed test. 
C. Tandem Stand  
1. Now I will show you the third movement. 
2. (Demonstrate) Now I want you to try to stand with the heel of one foot in front of 
and touching the toes of the other foot for about 10 seconds. You may put either 
foot in front, whichever is more comfortable  
for you.  
3. You may use your arms, bend your knees, or move your body to maintain your 
balance, but try not  
to move your feet. Try to hold this position until I tell you to stop. 
4. Supply just enough support to the patient’s arm to prevent loss of balance. 
5. When the patient has his/her feet together, ask “Are you ready?” 
6. Then let go and begin timing as you say, “Ready, begin.” 
7. Stop the stopwatch and say “Stop” after 10 seconds or when the patient steps out of 
position or grabs your arm. 
2. GAIT SPEED TEST  
Now I am going to observe how you normally walk. If you use a cane or other 
walking aid and you feel you need it to walk a short distance, then you may use it.  
A. First Gait Speed Test 
1. This is our walking course. I want you to walk to the other end of the course at 
your usual speed, just as if you were walking down the street to go to the store. 
2. Demonstrate the walk for the patient. 
3. Walk all the way past the other end of the tape before you stop. Do you feel this 
would be safe? 
4. Have the patient stand with both feet touching the starting line. 
5. When I want you to start, I will say: “Ready, begin.” When the patient acknowledges 
this instruction say: “Ready, begin.” 
6. Press the start/stop button to start the stopwatch as the patient begins walking. 
7. Stop timing when one of the patient’s feet is completely across the end line. 
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B. Second Gait Speed Test  
1. Now I want you to repeat the walk. Remember to walk at your usual pace, and go 
all the way past the other end of the course. 
2. Have the patient stand with both feet touching the starting line. 
3. When I want you to start, I will say: “Ready, begin.” When the patient acknowledges 
this instruction say: “Ready, begin.” 
4. Press the start/stop button to start the stopwatch as the patient begins walking. 
5. Walk behind and to the side of the patient. 
6. Stop timing when one of the patient’s feet is completely across the end line. 
  
3. CHAIR STAND TEST  
A. Single Chair Stand  
1. Let’s do the last movement test. Do you think it would be safe for you to try to 
stand up from a chair without using your arms? 
2. This test measures the strength in your legs. 
3. (Demonstrate and explain the procedure.) First, fold your arms across your chest 
and sit so that your feet are on the floor; then stand up keeping your arms folded 
across your chest. 
4. Please stand up keeping your arms folded across your chest. Are you ready? 
Stand. (Record result). 
5. If patient cannot rise without using arms, say “Okay, try to stand up using your arms. 
Are you ready? Stand.” This is the end of their test. Record result and go to the scoring 
page.  
B. Repeated Chair Stands  
1. Do you think it would be safe for you to try to stand up from a chair five times 
without using your arms? 
2.  Please stand up straight as QUICKLY as you can five times, without stopping in 
between. After standing up each time, sit down and then stand up again. Keep 
your arms folded across your chest. I’ll be timing you with a stopwatch. 
Remember, if you cannot complete this test or if you feel it would be unsafe to do 
so tell me and we will quit. 
3. When the patient is properly seated, say: “Are you ready? Stand” and begin timing. 
4. Count out loud as the patient arises each time, up to five times. 
5. Stop if patient becomes tired or short of breath during repeated chair stands. 
6. Stop the stopwatch when he/she has straightened up completely for the fifth time. 
7. Also stop: 
• If patient uses his/her arms 
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• After 1 minute, if patient has not completed rises 
• At your discretion, if concerned for patient’s safety 
8. If the patient stops and appears to be fatigued before completing the five stands, confirm 
this by asking “Can you continue?” 
9. If patient says “Yes,” continue timing. If patient says “No,” stop the stopwatch. 
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Appendix C: Timed Up & Go Test (TUG) Instructions  
 
Directions: 
The timed “Up and Go” test measures, in seconds, the time taken by an individual to stand up 
from a standard arm chair (approximate seat height of 46 cm [18in], arm height 65 cm [25.6 in]), 
walk a distance of 3 meters (118 inches, approximately 10 feet), turn, walk back to the chair, 
and sit down. The subject wears their regular footwear and uses their customary walking aid 
(none, cane, walker). No physical assistance is given. They start with their back against the 
chair, their arms resting on the armrests, and their walking aid at hand. They are instructed that, 
on the word “go” they are to get up and walk at your normal pace to a line on the floor 3 meters 
away, turn, return to the chair and sit down again. The subject walks through the test once 
before being timed in order to become familiar with the test. Either a stopwatch or a wristwatch 
with a second hand can be used to time the trial. 
 
Instructions to the patient: 
“When I say ‘go’ I want you to stand up and walk to the line, turn and then walk back to the chair 
and sit down again. Walk at your normal pace.” 
 
Scoring: 
Time for ‘Up and Go’ test _________sec.        
 Unstable on turning?    
 Walking aid used?    Type of aid: ___________ 
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Appendix D: Self-Efficacy for Exercise Scale 
 
 
How confident are you right now that you could exercise 3 times per week for 20 minutes 
if: 
  Not                             Very 
  Confident            Confident 
      
1.  You were worried the exercise would cause further pain  0  1  2  3  4  5  6  7  8  9  10 
2.  You were bored by the program or activity 0  1  2  3  4  5  6  7  8  9  10 
3.  You were not sure exactly what exercises to do 0  1  2  3  4  5  6  7  8  9  10 
4.  You had to exercise alone 0  1  2  3  4  5  6  7  8  9  10 
5.  You did not enjoy it 0  1  2  3  4  5  6  7  8  9  10 
6.  You were too busy with other activities 0  1  2  3  4  5  6  7  8  9  10 
7.  You felt tired during or after exercise 0  1  2  3  4  5  6  7  8  9  10 
8.  You felt stressed 0  1  2  3  4  5  6  7  8  9  10 
9.  You felt depressed 0  1  2  3  4  5  6  7  8  9  10 
10.  You were afraid the exercise would make you fall 0  1  2  3  4  5  6  7  8  9  10 
11.  You felt pain when exercising 0  1  2  3  4  5  6  7  8  9  10 
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Appendix E: Geriatric Depression Scale 
 
 
Instructions: 
 
Circle the answer that best describes how you felt  
over the past week. 
 
 
 1. Are you basically satisfied with your life? yes no 
 2. Have you dropped many of your activities and  
interests? 
  
yes no 
 3. Do you feel that your life is empty? yes no 
 4. Do you often get bored? yes no 
 5. Are you in good spirits most of the time? yes no 
 6. Are you afraid that something bad is going to  
happen to you? 
  
yes no 
 7. Do you feel happy most of the time? yes no 
 8. Do you often feel helpless? yes no 
 9. Do you prefer to stay at home, rather than going out 
and doing things? 
  
yes no 
 10. Do you feel that you have more problems with  
memory than most? 
  
yes no 
 11. Do you think it is wonderful to be alive now? yes no 
 12. Do you feel worthless the way  you are now? yes no 
 13. Do you feel full of energy? yes no 
 14. Do you feel that your situation is hopeless? yes no 
 15. Do you think that most people are better off than 
you are? 
  
yes no 
 Total Score  
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Appendix F: Lubben Social Network Scale-6 (LSNS-6) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 141 
 
Appendix G: Numeric Pain Rating (NPR) Scale 
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Appendix I: Data Analysis Plan  
 
Research 
questions/Hypotheses 
Unit of 
Analysis 
Variable Measurement 
tool 
Level of 
Measurement 
Statistical Test 
Descriptive Questions 
1. What are the self-
efficacy for exercise, 
depression, and social 
support of older adults 
living in RCACs?  
Resident 
subject 
-Self-efficacy for 
exercise 
-Depression 
-Social support 
-SEE 
-GDS-15 
-LSNS-6 
All ordinal Descriptive 
(Frequency, 
mean, SD, 
range)   
 
2. What are the muscle 
mass, strength, and 
function of older adults 
living in RCACs? 
Resident 
subject 
-Muscle mass 
-Muscle strength 
-Muscle function 
 
-Muscle mass 
-Grip strength 
-Gait speed 
-Chair rise 
-SPPB 
-TUG 
-Jump power 
All ordinal 
 
Descriptive 
(Frequency, 
mean, SD, 
range)   
 
Hypotheses 
1. Participants with high 
self-efficacy for exercise 
will have greater muscle 
mass, strength, and 
function than those with 
low self-efficacy for 
exercise 
Resident 
subject 
IV:  
-Self-efficacy for 
exercise 
DVs: 
-Muscle mass 
-Muscle strength 
-Muscle function 
 
 
 
 
-SEE  
 
 
-Muscle mass 
-Grip strength 
-Gait speed 
-Chair rise 
-SPPB 
-TUG 
- Jump power 
All ordinal 
 
 
t-test 
2. Participants without 
depressive symptoms 
will have greater muscle 
mass, strength, and 
function than those with 
depressive symptoms 
Resident 
subject 
IV: 
-Depression 
DVs: 
-Muscle mass 
-Muscle strength 
-Muscle function 
 
 
 
 
 
-GDS-15 
 
-Muscle mass 
-Grip strength 
-Gait speed 
-Chair rise 
-SPPB 
-TUG 
- Jump power  
All ordinal 
 
t-test 
3.Participants with high 
social support will have 
greater muscle mass, 
strength, and function 
than those with low 
social support 
Resident 
subject 
IV: 
-Social support  
DVs: 
-Muscle mass 
-Muscle strength 
-Muscle function 
 
 
-LSNS-6 
 
-Muscle mass 
-Grip strength 
-Gait speed 
-Chair rise 
All ordinal  t-test 
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-SPPB 
-TUG 
- Jump power  
4. Weight corrected jump 
power obtained by MM 
correlates well with other 
traditional muscle 
function and strength 
tests, including SPPB, 
TUG, and grip strength. 
Resident 
subject 
-Muscle function 
-Muscle strength  
-Grip strength 
-Gait speed 
-Chair rise 
-SPPB 
-TUG 
- Jump power  
All ordinal  Correlation 
Coefficient 
Values   
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